Sabra Health Care REIT (SBRA) 10-Q 5 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information Document	3 Months Ended
	Mar. 31, 2014	1-May-14
Entity Information [Line Items]	'	'
Entity Registrant Name	'Sabra Health Care REIT, Inc.	'
Entity Central Index Key	'0001492298	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Amendment Flag	'false	'
Entity Common Stock, Shares Outstanding	'	39,213,151

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets	'	'
Real estate investments, net of accumulated depreciation of $160,229 and $151,078 as of March 31, 2014 and December 31, 2013, respectively	$1,021,704	$915,418
Loans receivable and other investments, net	199,603	185,293
Cash and cash equivalents	4,286	4,308
Restricted cash	6,364	5,352
Deferred tax assets	24,212	24,212
Prepaid expenses, deferred financing costs and other assets	75,187	63,252
Total assets	1,331,356	1,197,835
Liabilities and stockholders’ equity	'	'
Mortgage notes payable	130,106	141,328
Secured revolving credit facility	162,000	135,500
Senior unsecured notes payable	550,000	414,402
Accounts payable and accrued liabilities	26,315	22,229
Tax liability	24,212	24,212
Total liabilities	892,633	737,671
Commitments and contingencies (Note 12)	'	'
Equity	'	'
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 issued and outstanding as of March 31, 2014 and December 31, 20123	58	58
Common stock, $.01 par value; 125,000,000 shares authorized, 39,143,251 and 38,788,745 shares issued and outstanding as of March 31, 2014 and December 31, 2013, respectively	391	388
Additional paid-in capital	537,288	534,639
Cumulative distributions in excess of net income	-98,996	-74,921
Total Sabra Health Care REIT. Inc. stockholders’ equity	438,741	460,164
Noncontrolling interests	-18	0
Total equity	438,723	460,164
Total liabilities and stockholders’ equity	$1,331,356	$1,197,835

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parentheticals) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 21, 2013
In Thousands, except Share data, unless otherwise specified
Assets	'	'	'
Accumulated depreciation	$160,229	$151,078	'
Equity	'	'	'
Preferred stock, par value	$0.01	$0.01	'
Preferred stock, shares authorized	10,000,000	10,000,000	'
Preferred stock, shares issued	5,750,000	5,750,000	5,750,000
Preferred stock, shares outstanding	5,750,000	5,750,000	'
Common stock, par value	$0.01	$0.01	'
Common stock, shares authorized	125,000,000	125,000,000	'
Common stock, shares issued	39,143,251	38,788,745	'
Common stock, shares outstanding	39,143,251	38,788,745	'

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Income (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Revenues:	'	'
Rental income	$36,093	$31,475
Interest and other income	4,757	547
Total revenues	40,850	32,022
Expenses:	'	'
Depreciation and amortization	9,350	8,246
Interest	11,134	10,002
General and administrative	5,853	4,717
Total expenses	26,337	22,965
Loss on extinguishment of debt	-22,134	0
Other income (expense)	300	500
Total other income (expense)	-21,834	500
Net (loss) income	-7,321	9,557
Net loss attributable to noncontrolling interests	18	0
Net (loss) income attributable to Sabra Health Care REIT, Inc	-7,303	9,557
Preferred stock dividends	-2,561	-304
Net income attributable to common stockholders	($9,864)	$9,253
Net income per common share, basic (USD per shares)	($0.25)	$0.25
Net income per common share, diluted (USD per shares)	($0.25)	$0.25
Weighted-average number of common shares outstanding, basic (in shares)	38,968,403	37,286,121
Weighted-average number of common shares outstanding, diluted (in shares)	38,968,403	37,739,964

Condensed_Consolidated_Stateme1

Condensed Consolidated Statement of Stockholders' Equity (USD $)

Total

Preferred Stock [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Cumulative Distributions in Excess of Net Income [Member]

Total Stockholders' Equity Before Noncontrolling Interests [Member]

Noncontrolling Interest [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

In Thousands, except Share data, unless otherwise specified

Additional Paid-in Capital [Member]

Total Stockholders' Equity Before Noncontrolling Interests [Member]

Additional Paid-in Capital [Member]

Total Stockholders' Equity Before Noncontrolling Interests [Member]

Beginning balance at Dec. 31, 2012

$305,488

$0

$371

$353,861

($48,744)

$305,488

$0

'

'

'

'

'

'

'

Beginning balance (shares) at Dec. 31, 2012

'

0

37,099,209

'

'

'

'

'

'

'

'

'

'

'

Increase (Decrease) in Stockholders' Equity [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net (loss) income

9,557

'

'

'

9,557

9,557

0

'

'

'

'

'

'

'

Amortization of stock based compensation

2,569

'

'

2,569

'

2,569

'

'

'

'

'

'

'

'

Stock issuance, Value

'

58

'

'

'

'

'

138,376

138,318

138,376

-2,735

2

-2,737

-2,735

Stock issuance, Shares

'

5,750,000

'

'

'

'

'

'

'

'

'

234,734

'

'

Dividends, Preferred Stock, Cash

'

'

'

'

-304

-304

'

'

'

'

'

'

'

'

Common dividends

-12,811

'

'

'

-12,811

-12,811

'

'

'

'

'

'

'

'

Ending balance at Mar. 31, 2013

440,140

58

373

492,011

-52,302

440,140

0

'

'

'

'

'

'

'

Ending balance (shares) at Mar. 31, 2013

'

5,750,000

37,333,943

'

'

'

'

'

'

'

'

'

'

'

Beginning balance at Dec. 31, 2013

460,164

58

388

534,639

-74,921

460,164

0

'

'

'

'

'

'

'

Beginning balance (shares) at Dec. 31, 2013

'

5,750,000

38,788,745

'

'

'

'

'

'

'

'

'

'

'

Increase (Decrease) in Stockholders' Equity [Roll Forward]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net (loss) income

-7,321

'

'

'

-7,303

-7,303

-18

'

'

'

'

'

'

'

Amortization of stock based compensation

2,689

'

'

2,689

'

2,689

'

'

'

'

'

'

'

'

Stock issuance, Value

'

'

'

'

'

'

'

'

'

'

-37

3

-40

-37

Stock issuance, Shares

'

'

'

'

'

'

'

'

'

'

'

354,506

'

'

Dividends, Preferred Stock, Cash

'

'

'

'

-2,561

-2,561

'

'

'

'

'

'

'

'

Common dividends

-14,211

'

'

'

-14,211

-14,211

'

'

'

'

'

'

'

'

Ending balance at Mar. 31, 2014

$438,723

$58

$391

$537,288

($98,996)

$438,741

($18)

'

'

'

'

'

'

'

Ending balance (shares) at Mar. 31, 2014

'

5,750,000

39,143,251

'

'

'

'

'

'

'

'

'

'

'

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Stockholders' Equity (Parenthetical) (USD $)	0 Months Ended	3 Months Ended
	Jan. 23, 2014	Mar. 31, 2014	Mar. 31, 2013
Common dividends	$0.36	$0.36	$0.34

Condensed_Consolidated_Stateme3

Condensed Consolidated Statement of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net (loss) income	($7,321)	$9,557
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	9,350	8,246
Non-cash interest income adjustments	70	5
Amortization of deferred financing costs	945	766
Stock-based compensation expense	2,513	2,474
Amortization of premium	-33	-199
Loss on extinguishment of debt	1,338	0
Straight-line rental income adjustments	-4,186	-3,683
Write-off of straight-line rental income	99	0
Change in fair value of contingent consideration	-300	-500
Changes in operating assets and liabilities:	'	'
Prepaid expenses and other assets	-2,152	-513
Accounts payable and accrued liabilities	2,086	6,513
Restricted cash	-1,202	-1,063
Net cash provided by operating activities	1,207	21,603
Cash flows from investing activities:	'	'
Acquisitions of real estate	-108,650	0
Origination of loans receivable	-19,428	-12,873
Preferred equity investment	-5	-4,646
Additions to real estate	-56	0
Net proceeds from the sale of real estate	0	2,208
Net cash used in investing activities	-128,139	-15,311
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	350,000	0
Principal payments on senior unsecured notes	-211,250	0
Proceeds from secured revolving credit facility	50,000	0
Payments on secured revolving credit facility	-23,500	-92,500
Proceeds from mortgage notes	46,103	0
Principal payments on mortgage notes payable	-57,325	-989
Payments of deferred financing costs	-9,873	-72
Issuance of preferred stock	0	138,983
Issuance of common stock	-648	-2,534
Dividends paid	-16,597	-12,716
Net cash provided by (used in) financing activities	126,910	30,172
Net decrease in cash and cash equivalents	-22	36,464
Cash and cash equivalents, beginning of period	4,308	17,101
Cash and cash equivalents, end of period	4,286	53,565
Supplemental disclosure of cash flow information:	'	'
Interest paid	$7,219	$3,064

BUSINESS

BUSINESS	3 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Business	'
	BUSINESS
	Overview
	Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) was incorporated on May 10, 2010 as a wholly owned subsidiary of Sun Healthcare Group, Inc. (“Old Sun”) and commenced operations on November 15, 2010. Sabra elected to be treated as a real estate investment trust (“REIT”) with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011. Sabra believes that it has been organized and operated, and it intends to continue to operate, in a manner to qualify as a REIT. Sabra’s primary business consists of acquiring, financing and owning real estate property to be leased to third party tenants in the healthcare sector. Sabra owns substantially all of its assets and properties and conducts its operations through Sabra Health Care Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), of which Sabra is the sole general partner, or by subsidiaries of the Operating Partnership. As of March 31, 2014, Sabra’s investment portfolio consisted of 129 real estate properties held for investment and leased to operators/tenants under triple-net lease agreements (consisting of (i) 102 skilled nursing/post-acute facilities, (ii) 25 senior housing facilities, and (iii) two acute care hospitals), 11 debt investments (consisting of (i) four mortgage loans, (ii) three construction loans, (iii) one mezzanine loan, and (iv) three pre-development loans) and two preferred equity investments. Included in the 129 real estate properties held for investment is one 100% owned senior housing facility leased to a 50%/50% RIDEA-compliant joint venture tenant.

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Principles of Consolidation and Basis of Presentation
	The condensed consolidated financial statements include the accounts of Sabra, its wholly owned subsidiaries and a consolidated variable interest entity (“VIEs”). All significant intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”).
	GAAP requires the Company to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of VIEs. A VIE is broadly defined as an entity with one or more of the following characteristics: (a) the total equity investment at risk is insufficient to finance the entity's activities without additional subordinated financial support; (b) as a group, the holders of the equity investment at risk lack (i) the ability to make decisions about the entity's activities through voting or similar rights, (ii) the obligation to absorb the expected losses of the entity, or (iii) the right to receive the expected residual returns of the entity; or (c) the equity investors have voting rights that are not proportional to their economic interests, and substantially all of the entity's activities either involve, or are conducted on behalf of, an investor that has disproportionately few voting rights. If the Company were determined to be the primary beneficiary of the VIE, the Company would consolidate investments in the VIE. The Company may change its original assessment of a VIE due to events such as modifications of contractual arrangements that affect the characteristics or adequacy of the entity's equity investments at risk and the disposal of all or a portion of an interest held by the primary beneficiary.
	The Company identifies the primary beneficiary of a VIE as the enterprise that has both: (i) the power to direct the activities of the VIE that most significantly impact the entity's economic performance; and (ii) the obligation to absorb losses or the right to receive benefits of the VIE that could be significant to the entity. The Company performs this analysis on an ongoing basis.
	On January 1, 2014, the Company, through a wholly owned subsidiary, entered into a 50%/50% RIDEA-compliant senior housing operations joint venture. This joint venture was formed to indirectly, through subsidiary companies, operate senior housing, memory care, or other applicable businesses. The joint venture currently includes one senior housing facility, Stoney River Marshfield, a 60-bed assisted living facility located in Marshfield, Wisconsin. As of March 31, 2014, this joint venture is consolidated in the accompanying condensed consolidated financial statements as it is deemed to be a VIE and the Company is the primary beneficiary. The carrying value of the facility as of March 31, 2014 and December 31, 2013 was $9.0 million and $9.1 million, respectively, and is included in Real estate investments in the accompanying condensed consolidated balance sheets. As of March 31, 2014, the 50%/50% RIDEA-compliant joint venture was not material to the Company’s results of operations, financial condition or cash flows.
	As it relates to investments in loans, in addition to the Company's assessment of VIEs and whether the Company is the primary beneficiary of those VIEs, the Company evaluates the loan terms and other pertinent facts to determine if the loan investment should be accounted for as a loan or as a real estate joint venture. If an investment has the characteristics of a real estate joint venture, including if the Company participates in the majority of the borrower's expected residual profit, the Company would account for the investment as an investment in a real estate joint venture and not as a loan investment. Expected residual profit is defined as the amount of profit, whether called interest or another name, such as an equity kicker, above a reasonable amount of interest and fees expected to be earned by a lender. At March 31, 2014, none of the Company's investments in loans are accounted for as real estate joint ventures.
	As it relates to investments in joint ventures, based on the type of rights held by the limited partner(s), GAAP may preclude consolidation by the sole general partner in certain circumstances in which the general partner would otherwise consolidate the joint venture. The Company assesses limited partners' rights and their impact on the presumption of control of the limited partnership by the sole general partner when an investor becomes the sole general partner, and the Company reassesses if: there is a change to the terms or in the exercisability of the rights of the limited partners; the sole general partner increases or decreases its ownership of limited partnership interests; or there is an increase or decrease in the number of outstanding limited partnership interests. The Company also applies this guidance to managing member interests in limited liability companies.
	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial information as contained within the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”), including the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, the unaudited condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for financial statements. In the opinion of management, the financial statements for the unaudited interim periods presented include all adjustments, which are of a normal and recurring nature, necessary for a fair statement of the results for such periods. Operating results for the three months ended March 31, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information, refer to the Company’s consolidated financial statements and notes thereto for the year ended December 31, 2013 included in the Company’s 2013 Annual Report on Form 10-K filed with the SEC.
	Use of Estimates
	The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
	Recently Issued Accounting Standards Update
	On April 10, 2014, the FASB issued Accounting Standards Update No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU No. 2014-08”), which changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. The standard no longer precludes presentation as a discontinued operation if (i) there are operations and cash flows of the component that have not been eliminated from the reporting entity’s ongoing operations, or (ii) there is significant continuing involvement with a component after its disposal. ASU No. 2014-08 is effective for public entities for interim and annual periods beginning after December 15, 2014, and will be applied prospectively.  The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.

RECENT_REAL_ESTATE_ACQUISITION

RECENT REAL ESTATE ACQUISITIONS (Notes)	3 Months Ended
	Mar. 31, 2014
RECENT REAL ESTATE ACQUISITIONS [Abstract]	'
Recent Real Estate Acquisitions	'
	RECENT REAL ESTATE ACQUISITIONS
	During the three months ended March 31, 2014, the Company acquired six skilled nursing facilities and two senior housing facilities for consideration totaling $117.7 million. The consideration was allocated as follows (in thousands):
					Intangibles
	Land		Building and Improvements		Tenant Origination and Absorption Costs		Tenant Relationship		Total Consideration
	$	9,640	$	105,741	$	1,741	$	586	$	117,708
	As of March 31, 2014, the purchase price allocations for acquisitions completed during the three months ended March 31, 2014 are preliminary pending the receipt of information necessary to complete the valuation of certain tangible and intangible assets and liabilities and therefore are subject to change.
	The tenant origination and absorption costs intangible assets and tenant relationship intangible assets acquired in connection with these acquisitions have weighted-average amortization periods as of the date of acquisition of 11 years and 21 years, respectively.
	For the three months ended March 31, 2014, the Company recognized $1.2 million and $0.5 million of total revenues and net income attributable to common stockholders, respectively, from these properties.
	Acquisition Earn-Out
	In connection with its acquisition of four skilled nursing facilities and two senior housing facilities (the “Nye Portfolio”) for $90.0 million, the Company may pay an earn-out based on incremental portfolio value created through the improvement of current operations as well as through expansion and conversion projects associated with these facilities. The earn-out amount will be determined based on portfolio performance following the third anniversary of the master lease. The Company estimated a contingent consideration liability of $3.2 million at the time of purchase. As of March 31, 2014, based on the performance of the Nye Portfolio, the contingent consideration liability remains at $3.2 million and is included in accounts payable and accrued liabilities in the accompanying condensed consolidated balance sheet.

REAL_ESTATE_INVESTMENTS

REAL ESTATE INVESTMENTS	3 Months Ended
	Mar. 31, 2014
Real Estate Investments, Net [Abstract]	'
Real Estate Investments	'
	REAL ESTATE PROPERTIES HELD FOR INVESTMENT
	The Company’s real estate properties held for investment consisted of the following (dollars in thousands):
	As of March 31, 2014
	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Post-Acute		102		11,460			$	824,328	$	(138,529	)	$	685,799
	Senior Housing		25		1,826			181,544		(14,563		)	166,981
	Acute Care Hospitals		2		124			175,807		(6,971		)	168,836
			129		13,410			1,181,679		(160,063		)	1,021,616
	Corporate Level							254		(166		)	88
								$	1,181,933	$	(160,229	)	$	1,021,704
	As of December 31, 2013
	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Post-Acute		96		10,826			$	737,188	$	(132,068	)	$	605,120
	Senior Housing		23		1,518			153,247		(13,337		)	139,910
	Acute Care Hospitals		2		124			175,807		(5,520		)	170,287
			121		12,468			1,066,242		(150,925		)	915,317
	Corporate Level							254		(153		)	101
								$	1,066,496	$	(151,078	)	$	915,418
		March 31, 2014			December 31, 2013
	Building and improvements	$	979,097		$	879,926
	Furniture and equipment	57,193			50,567
	Land improvements	4,392			4,392
	Land	141,251			131,611
		1,181,933			1,066,496
	Accumulated depreciation	(160,229		)	(151,078		)
		$	1,021,704		$	915,418
	Forest Park - Frisco Contingent Consideration
	On October 22, 2013, the Company purchased Forest Park Medical Center - Frisco, a 54-bed acute care hospital located in Frisco, Texas. The total purchase price was $119.8 million, of which approximately $10.5 million is being held in escrow. This amount will be held in escrow for up to 20 months following the purchase date and the amount ultimately released from escrow is contingent on the tenant achieving certain performance hurdles. The seller will be paid a fee of $0.5 million per annum during the escrow period. As of October 22, 2013, the amount the Company expected to release from escrow was valued at $7.3 million and is treated as contingent consideration. As of March 31, 2014, based on the performance of the facility the contingent consideration liability is estimated at $7.2 million and is included in accounts payable and accrued liabilities in the accompanying condensed consolidated balance sheets. As of March 31, 2014, the $10.5 million held in escrow was included in prepaid expenses, deferred financing costs and other assets in the accompanying condensed consolidated balance sheets. During the three months ended March 31, 2014, the Company recorded an adjustment to the contingent consideration liability of $0.3 million and included this amount in other income on the accompanying condensed consolidated statements of (loss) income. Subsequent to March 31, 2014, $5.3 million was released from escrow to the seller as the result of the facility achieving certain of its performance hurdles. The remaining $5.2 million remains in escrow with its release contingent on the facility meeting additional performance hurdles.
	Operating Leases
	As of March 31, 2014, all of the Company’s real estate properties were leased under triple-net operating leases with expirations ranging from seven to 21 years. As of March 31, 2014, the leases had a weighted-average remaining term of 11 years. The leases include provisions to extend the lease terms and other negotiated terms and conditions. The Company, through its subsidiaries, retains substantially all of the risks and benefits of ownership of the real estate assets leased to the tenants. In addition, the Company may receive additional security under these operating leases in the form of letters of credit and security deposits from the lessee or guarantees from the parent of the lessee or other related parties. Security deposits received in cash related to tenant leases are included in accounts payable and accrued liabilities in the accompanying condensed consolidated balance sheets and totaled $1.7 million and $1.6 million as of March 31, 2014 and December 31, 2013, respectively. As of March 31, 2014, 81 of the Company's 129 real estate properties held for investment were leased to subsidiaries of Genesis.
	The Company monitors the creditworthiness of its tenants by reviewing credit ratings (if available) and evaluating the ability of the tenants to meet their lease obligations to the Company based on the tenants’ financial performance, including the evaluation of any parent guarantees (or the guarantees of other related parties) of tenant lease obligations. Because formal credit ratings may not be available for most of the Company’s tenants, the primary basis for the Company’s evaluation of the credit quality of its tenants (and more specifically the tenants’ ability to pay their rent obligations to the Company) is the tenants’ lease coverage ratios. These coverage ratios include earnings before interest, taxes, depreciation, amortization and rent (“EBITDAR”) to rent coverage and earnings before interest, taxes, depreciation, amortization, rent and management fees (“EBITDARM”) to rent coverage at the facility level and consolidated EBITDAR to total fixed charge coverage at the parent guarantor level when such a guarantee exists (currently the Genesis lease portfolio). The Company obtains various financial and operational information from its tenants each month and reviews this information in conjunction with the above-described coverage metrics to determine trends and the operational and financial impact of the environment in the industry (including the impact of government reimbursement) and the management of the tenant’s operations. These metrics help the Company identify potential areas of concern relative to its tenants’ credit quality and ultimately the tenants’ ability to generate sufficient liquidity to meet its obligations, including its obligation to continue to pay the rent due to the Company.
	As of March 31, 2014, the future minimum rental payments from the Company’s properties under non-cancelable operating leases was as follows (in thousands):
	April 1, 2014 through December 31, 2014	$	101,053
	2015	138,355
	2016	141,204
	2017	144,746
	2018	148,382
	Thereafter	965,518
		$	1,639,258

LOANS_RECEIVABLE_AND_OTHER_INV

LOANS RECEIVABLE AND OTHER INVESTMENTS (Notes)	3 Months Ended
	Mar. 31, 2014
Loans Receivable and Other Investments [Abstract]	'
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	'
	LOANS RECEIVABLE AND OTHER INVESTMENTS
	As of March 31, 2014, the Company’s loans receivable and other investments consisted of the following (dollars in thousands):
	Investment	Quantity	Facility Type	Principal Balance as of March 31, 2014		Book Value as of March 31, 2014		Weighted Average Contractual Rate		Weighted Average Annualized Effective Rate		Maturity Date
	Loans Receivable:
	Mortgage	4	Skilled Nursing / Senior Housing / Acute Care Hospital	$	149,161	$	149,648	8.2	%	8.1	%	10/31/16 - 1/31/18
	Construction	3	Acute Care Hospital / Memory Care	33,044		33,375		7.5	%	7.4	%	9/30/16 - 10/31/18
	Mezzanine	1	Skilled Nursing	6,517		6,541		12	%	11.6	%	12/27/14
	Pre-development	3	Senior Housing	1,884		1,965		9	%	7.8	%	8/16/15 - 1/28/17
		11		190,606		191,529		8.2	%	8.1	%
	Other Investments:
	Preferred Equity	2	Skilled Nursing / Memory Care	7,979		8,074		15	%	15	%	NA
	Total	13		$	198,585	$	199,603	8.5	%	8.4	%
	Chai Acquisition Option Exercise
	On March 5, 2014, the Company exercised its option to purchase two skilled nursing facilities indirectly securing the mezzanine loan for $24.5 million.
	At the closing of the acquisition, $5.8 million of the sales proceeds were used to repay a portion of the mezzanine loan, resulting in the Company funding an additional $18.7 million for the acquisition and leaving $6.5 million outstanding under the mezzanine loan. The Company continues to have an option to purchase up to an additional $25.5 million of the remaining ten properties securing the mezzanine loan.

DEBT

DEBT	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Debt	'
		DEBT
	Mortgage Indebtedness
	The Company’s mortgage notes payable consisted of the following (dollars in thousands):
	Interest Rate Type	Book Value as of			Book Value as of			Weighted Average			Maturity
		31-Mar-14			December 31, 2013			Effective Interest Rate at			Date
								31-Mar-14
	Fixed Rate	$	100,335		$	54,688		3.66	%		May 2031 - June 2047
	Variable Rate(1)	29,771			86,640			5	%		Aug-15
		$	130,106		$	141,328		3.97	%
	(1) Contractual interest rates under variable rate mortgages are equal to the 90-day LIBOR plus 4.0% (subject to a 1.0% LIBOR floor).
	Mortgage Debt Refinancing. On January 21, 2014, the Company refinanced $44.8 million of existing variable rate mortgage indebtedness due August 2015 with mortgages guaranteed by the United States Department of Housing and Urban Development (“HUD”) at an interest rate of 4.25% with maturities between 2039 and 2044. In connection with these refinancings, the Company wrote off $0.5 million in unamortized deferred financing costs during the three months ended March 31, 2014 and included this amount in loss on extinguishment of debt on the accompanying condensed consolidated statements of (loss) income. Subsequent to March 31, 2014, the Company completed the refinancing of $11.6 million of variable rate mortgage indebtedness that was previously repaid with funds from its Revolving Credit Facility. This new mortgage loan is guaranteed by HUD, has an interest rate of 4.10% and matures in 2044.
	Senior Unsecured Notes
	5.5% Notes due 2021. On January 23, 2014, the Operating Partnership and Sabra Capital Corporation, wholly owned subsidiaries of the Company (the “Issuers”), completed an underwritten public offering of $350.0 million aggregate principal amount of 5.5% senior unsecured notes (the “2021 Notes”). The 2021 Notes were sold at par, resulting in gross proceeds of $350.0 million and net proceeds of approximately $340.8 million after deducting underwriting discounts and other offering expenses. The 2021 Notes accrue interest at a rate of 5.5% per annum payable semiannually on February 1 and August 1 of each year.
	The 2021 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after February 1, 2017, at the redemption prices set forth in the supplemental indenture governing the 2021 Notes (the “2021 Notes Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to February 1, 2017, the Issuers may redeem all or a portion of the 2021 Notes at a redemption price equal to 100% of the principal amount of the 2021 Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to February 1, 2017, the Issuers may redeem up to 35% of the principal amount of the 2021 Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 105.5% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the 2021 Notes are not redeemed, the 2021 Notes mature on February 1, 2021.
	5.375% Notes Due 2023. On May 23, 2013, the Issuers completed an underwritten public offering of $200.0 million aggregate principal amount of 5.375% senior unsecured notes (the “2023 Notes”). The 2023 Notes were sold at par, resulting in gross proceeds of $200.0 million and net proceeds of approximately $194.6 million after deducting underwriting discounts and other offering expenses. The 2023 Notes accrue interest at a rate of 5.375% per annum payable semiannually on June 1 and December 1 of each year.
	The 2023 Notes are redeemable at the option of the Issuers, in whole or in part, at any time, and from time to time, on or after June 1, 2018, at the redemption prices set forth in the supplemental indenture governing the 2023 Notes (the “2023 Notes Indenture”), plus accrued and unpaid interest to the applicable redemption date. In addition, prior to June 1, 2018, the Issuers may redeem all or a portion of the 2023 Notes at a redemption price equal to 100% of the principal amount of the 2023 Notes redeemed, plus a “make-whole” premium, plus accrued and unpaid interest to the applicable redemption date. At any time, or from time to time, on or prior to June 1, 2016, the Issuers may redeem up to 35% of the principal amount of the 2023 Notes, using the proceeds of specific kinds of equity offerings, at a redemption price of 105.375% of the principal amount to be redeemed, plus accrued and unpaid interest, if any, to the applicable redemption date. Assuming the 2023 Notes are not redeemed, the 2023 Notes mature on June 1, 2023.
	8.125% Notes due 2018. On October 27, 2010 and July 26, 2012, the Issuers issued $225.0 million and $100.0 million aggregate principal amount of 8.125% senior unsecured notes (the “2018 Notes”), respectively. Pursuant to exchange offers completed on March 14, 2011 and November 14, 2012, the Issuers exchanged the 2018 Notes that were issued in October 2010 and July 2012 for substantially identical 2018 Notes registered under the Securities Act of 1933, as amended. The 2018 Notes accrued interest at a rate of 8.125% per annum payable semiannually on May 1 and November 1 of each year.
	On June 24, 2013, pursuant to the terms of the indenture governing the 2018 Notes (the “2018 Notes Indenture”), the Issuers redeemed $113.8 million in aggregate principal amount of the outstanding 2018 Notes, representing 35% of the aggregate principal amount of the 2018 Notes outstanding. The 2018 Notes were redeemed at a redemption price of 108.125% of the principal amount redeemed, plus accrued and unpaid interest up to the redemption date. The redemption resulted in a $9.8 million loss on extinguishment of debt, including $9.3 million in payments made to noteholders for early redemption and $0.5 million of write-offs associated with unamortized deferred financing costs and issuance premium.
	On January 8, 2014, the Company commenced a cash tender offer with respect to any and all of the outstanding $211.3 million of the 2018 Notes. Pursuant to the tender offer, the Company retired $210.9 million of the 2018 Notes at a premium of 109.837%, plus accrued and unpaid interest, on January 23, 2014. Pursuant to the terms of the 2018 Notes Indenture, the remaining $0.4 million of the 2018 Notes were called and were retired on February 11, 2014 at a redemption price of 109.485% plus accrued and unpaid interest. The tender offer and redemption resulted in $21.6 million of tender offer and redemption related costs and write-offs for the three months ended March 31, 2014, including $20.8 million in payments made to noteholders for early redemption and $0.8 million of write-offs associated with unamortized deferred financing and premium costs. These amounts are included in loss on extinguishment of debt on the accompanying condensed consolidated statements of (loss) income.
	The obligations under the 2021 Notes and 2023 Notes (collectively, the “Senior Notes”) are fully and unconditionally guaranteed, jointly and severally, on an unsecured basis, by Sabra and certain of Sabra’s other existing and, subject to certain exceptions, future material subsidiaries; provided, however, that such guarantees are subject to release under certain customary circumstances.  See Note 10, “Summarized Condensed Consolidating Information” for additional information concerning the circumstances pursuant to which the guarantors will be automatically and unconditionally released from their obligations under the guarantees.
	The indentures governing the Senior Notes (the “Senior Notes Indentures”) contain restrictive covenants that, among other things, restrict the ability of Sabra, the Issuers and their restricted subsidiaries to: (i) incur or guarantee additional indebtedness; (ii) incur or guarantee secured indebtedness; (iii) pay dividends or distributions on, or redeem or repurchase, their capital stock; (iv) make certain investments or other restricted payments; (v) sell assets; (vi) create liens on their assets; (vii) enter into transactions with affiliates; (viii) merge or consolidate or sell all or substantially all of their assets; and (ix) create restrictions on the ability of Sabra’s restricted subsidiaries to pay dividends or other amounts to Sabra. Such limitations on distributions also include a limitation on the extent of allowable cumulative distributions made not to exceed the greater of (a) the sum of (x) 95% of cumulative Adjusted Funds from Operations and (y) the net proceeds from the issuance of common and preferred equity and (b) the minimum amount of distributions required for the Company to maintain its REIT status. The Senior Notes Indentures also provide for customary events of default, including, but not limited to, the failure to make payments of interest or premium, if any, on, or principal of, the Senior Notes, the failure to comply with certain covenants and agreements specified in the Senior Notes Indentures for a period of time after notice has been provided, the acceleration of other indebtedness resulting from the failure to pay principal on such other indebtedness prior to its maturity, and certain events of insolvency. If any event of default occurs, the principal of, premium, if any, and accrued interest on all the then outstanding Senior Notes may become due and payable immediately. The Company was in compliance with all applicable financial covenants under the Senior Notes Indentures related to the Senior Notes outstanding as of March 31, 2014.
	Revolving Credit Facility
	On July 29, 2013, the Operating Partnership entered into an amended and restated secured revolving credit facility (the “Revolving Credit Facility”) with certain lenders as set forth in the related credit agreement and Bank of America, N.A., as Administrative Agent, Swing Line Lender and L/C Issuer (each as defined in such credit agreement). The Revolving Credit Facility provides for a borrowing capacity of $375.0 million and includes an accordion feature that allows the Operating Partnership to increase the borrowing availability by up to an additional $225.0 million, subject to terms and conditions. The Revolving Credit Facility is secured by pledges of equity by the Company's wholly-owned subsidiaries that own certain of the Company's real estate assets. Borrowing availability under the Revolving Credit Facility is subject to a borrowing base calculation based on, among other factors, the mortgageability cash flow (as such term is defined in the related credit agreement). The Revolving Credit Facility has a maturity date of July 29, 2016, and includes a one year extension option. As of March 31, 2014, there was $162.0 million outstanding under the Company’s Revolving Credit Facility and $125.5 million available for borrowing.
	Borrowings under the Revolving Credit Facility bear interest on the outstanding principal amount at a rate equal to an applicable percentage plus, at the Operating Partnership's option, either (a) LIBOR or (b) a base rate determined as the greater of (i) the federal funds rate plus 0.5%, (ii) the prime rate, and (iii) one-month LIBOR plus 1.0% (referred to as the “Base Rate”). The applicable percentage for borrowings will vary based on the Consolidated Leverage Ratio, as defined in the Revolving Credit Facility, and will range from 2.50% to 3.50% per annum for LIBOR based borrowings and 1.50% to 2.50% per annum for borrowings at the Base Rate. As of March 31, 2014, the interest rate on the Revolving Credit Facility was 3.15%. In addition, the Operating Partnership is required to pay a facility fee to the lenders equal to between 0.35% and 0.50% per annum based on the amount of unused borrowings under the Revolving Credit Facility. During the three months ended March 31, 2014, the Company incurred $1.2 million in interest expense on amounts outstanding under the Revolving Credit Facility. During the three months ended March 31, 2014, the Company incurred $0.3 million of unused facility fees.
	The obligations of the Operating Partnership under the Revolving Credit Facility are guaranteed by Sabra and certain subsidiaries of Sabra.
	The Revolving Credit Facility contains customary covenants that include restrictions or limitations on the ability to make acquisitions and other investments, make distributions, incur additional indebtedness, engage in non-healthcare related business activities, enter into transactions with affiliates and sell or otherwise transfer certain assets as well as customary events of default. The Revolving Credit Facility also requires Sabra, through the Operating Partnership, to comply with specified financial covenants, which include a maximum leverage ratio, a minimum fixed charge coverage ratio and a minimum tangible net worth requirement. As of March 31, 2014, the Company was in compliance with all applicable financial covenants under the Revolving Credit Facility.
	Interest Expense
	During the three months ended March 31, 2014 and 2013, the Company incurred interest expense of $11.1 million and $10.0 million, respectively. Interest expense includes deferred financing costs amortization of $0.9 million and $0.8 million for the three months ended March 31, 2014 and 2013, respectively. As of March 31, 2014 and December 31, 2013, the Company had $7.7 million and $4.7 million, respectively, of accrued interest included in accounts payable and accrued liabilities on the accompanying condensed consolidated balance sheets.
	Maturities
	The following is a schedule of maturities for the Company’s outstanding debt as of March 31, 2014 (in thousands):
			Mortgage			Senior Notes			Revolving Credit Facility (1)			Total
			Indebtedness
	April 1, 2014 through December 31, 2014		$	2,416		$	—		$	—		$	2,416
	2015		31,637			—			—			31,637
	2016		2,553			—			162,000			164,553
	2017		2,634			—			—			2,634
	2018		2,717			—			—			2,717
	Thereafter		88,149			550,000			—			638,149
			$	130,106		$	550,000		$	162,000		$	842,106
	(1) Subject to a one-year extension option.

FAIR_VALUE_DISCLOSURES

FAIR VALUE DISCLOSURES	3 Months Ended
	Mar. 31, 2014
Fair Value Disclosures [Abstract]	'
Fair Value Disclosures	'
	FAIR VALUE DISCLOSURES
	The fair value for certain financial instruments is derived using a combination of market quotes, pricing models and other valuation techniques that involve significant management judgment. The price transparency of financial instruments is a key determinant of the degree of judgment involved in determining the fair value of the Company’s financial instruments.
	Financial instruments for which actively quoted prices or pricing parameters are available and whose markets contain orderly transactions will generally have a higher degree of price transparency than financial instruments whose markets are inactive or consist of non-orderly trades. The Company evaluates several factors when determining if a market is inactive or when market transactions are not orderly. The carrying values of cash and cash equivalents, restricted cash, secured revolving credit facility, accounts payable and accrued liabilities are reasonable estimates of fair value because of the short-term maturities of these instruments. Fair values for other financial instruments are derived as follows:
	Loans receivable: These instruments are presented in the accompanying condensed consolidated balance sheets at their amortized cost and not at fair value. The fair value of the loans receivable were estimated using an internal valuation model that considered the expected cash flows for the loans receivable, the underlying collateral value and other credit enhancements.
	Preferred equity investments: These instruments are presented in the accompanying condensed consolidated balance sheets at their cost and not at fair value. The fair value of the preferred equity investments were estimated using an internal valuation model that considered the expected future cash flows for the preferred equity investment, the underlying collateral value and other credit enhancements.
	Senior Notes: The fair values of the Senior Notes were determined using third-party market quotes derived from orderly trades.
	Mortgage indebtedness: The fair values of the Company’s mortgage notes payable were estimated using a discounted cash flow analysis based on management’s estimates of current market interest rates for instruments with similar characteristics, including remaining loan term, loan-to-value ratio, type of collateral and other credit enhancements.
	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of March 31, 2014 and December 31, 2013 whose carrying amounts do not approximate their fair value (in thousands):
		March 31, 2014								December 31, 2013
		Face				Carrying		Fair		Face		Carrying		Fair
		Value (1)				Amount (2)		Value		Value (1)		Amount (2)		Value
	Financial assets:
	Loans receivable	$	190,606			$	191,529	$	193,069	$	176,558	$	177,509	$	176,985
	Preferred equity investments	7,979				8,074		8,236		7,695		7,784		7,950
	Financial liabilities:
	Senior Notes	550,000				550,000		566,875		411,250		414,402		421,122
	Mortgage indebtedness	130,106				130,106		121,208		141,328		141,328		130,622
	(1) Face value represents amounts contractually due under the terms of the respective agreements.
	(2) Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).
	The Company determined the fair value of financial instruments as of March 31, 2014 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):
						Fair Value Measurements Using
						Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
		Total				(Level 1)		(Level 2)		(Level 3)
	Financial assets:
	Loans receivable	$	193,069			$	—	$	—	$	193,069
	Preferred equity investments	8,236				—		—		8,236
	Financial liabilities:
	Senior Notes	566,875				—		566,875		—
	Mortgage indebtedness	121,208				—		—		121,208
	Disclosure of the fair value of financial instruments is based on pertinent information available to the Company at the applicable dates and requires a significant amount of judgment. Despite increased capital market and credit market activity, transaction volume for certain financial instruments remains relatively low. This has made the estimation of fair values difficult and, therefore, both the actual results and the Company’s estimate of fair value at a future date could be materially different.
	During the three months ended March 31, 2014, the Company recorded the following amounts measured at fair value (in thousands):
						Fair Value Measurements Using
						Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
		Total				(Level 1)		(Level 2)		(Level 3)
	Recurring Basis:
	Contingent consideration	$	10,400			$	—	$	—	$	10,400
	The Company’s contingent consideration liability is the result of two acquisitions of real estate properties (see Note 3, “Recent Real Estate Acquisitions” and Note 4, “Real Estate Properties Held for Investment” for further details). In order to determine the fair value of the Company’s contingent consideration liability, the Company developed probability-weighted scenarios of the potential future performance of the tenant and the resulting payout from these scenarios. As of March 31, 2014, the total contingent consideration liability was valued at $10.4 million. The following reconciliation provides the details of activity during the three months ended March 31, 2014 for financial instruments recorded at fair value using Level 3 inputs:
	Balance as of December 31, 2013		$	7,500
	New contingent liability		3,200
	Decrease in contingent liability		(300		)
	Balance as of March 31, 2014		$	10,400
	The decrease in contingent liability was included as other income on the accompanying condensed consolidated statements of (loss) income for the three months ended March 31, 2014.

EQUITY

EQUITY	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Equity	'
	EQUITY
	Preferred Stock
	On March 21, 2013, the Company completed an underwritten public offering of 5.8 million shares of 7.125% Series A Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") at a price of $25.00 per share, pursuant to an effective registration statement. The Company received net proceeds of $138.3 million from the offering, after deducting underwriting discounts and other offering expenses.
	The holders of the Company’s Series A Preferred Stock rank senior to the Company’s common stock with respect to dividend rights and rights upon the Company’s liquidation, dissolution or winding up of its affairs. Holders of shares of the Series A Preferred Stock will generally have no voting rights.  However, if dividends on the Series A Preferred Stock are in arrears for six or more quarterly periods, whether or not consecutive, holders of shares of the Series A Preferred Stock will be entitled to vote for the election of two additional directors to serve on the Company’s board of directors until all accrued dividends for past dividend periods with respect to the Series A Preferred Stock have been paid or declared and a sum sufficient for the payment thereof set apart for payment. The holders of Series A Preferred Stock also have voting rights with respect to the Company in certain other circumstances. At March 31, 2014, there were no dividends in arrears.
	Generally, the Company is not permitted to redeem the Series A Preferred Stock prior to March 21, 2018, except in limited circumstances to preserve its status as a REIT and pursuant to the special optional redemption provision described below. On or after March 21, 2018, the Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, at any time or from time to time, for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends on such Series A Preferred Stock up to, but not including, the redemption date. In addition, upon the occurrence of a specified change of control (as described in the Articles Supplementary governing the Series A Preferred Stock), the Company may, at its option, redeem the Series A Preferred Stock, in whole or in part, within 120 days after the first date on which such change of control occurred, by paying $25.00 per share, plus any accrued and unpaid dividends to, but not including, the date of redemption. If the Company exercises any of its redemption rights relating to the Series A Preferred Stock, the holders of Series A Preferred Stock will not have the conversion right described below. The Series A Preferred Stock has no stated maturity and is not subject to mandatory redemption or any sinking fund.
	Upon the occurrence of a specified change of control, each holder of Series A Preferred Stock will have the right (unless, prior to the change of control conversion date specified in the Articles Supplementary governing the Series A Preferred Stock, the Company has provided or provides notice of its election to redeem the Series A Preferred Stock) to convert some or all of the shares of Series A Preferred Stock held by such holder into a number of shares of the Company’s common stock per share of Series A Preferred Stock to be converted equal to the lesser of:
	•	the quotient obtained by dividing (i) the sum of the $25.00 liquidation preference plus the amount of any accrued and unpaid dividends to, but not including, the change of control conversion date (unless the change of control conversion date is after a record date for a Series A Preferred Stock dividend payment and prior to the corresponding Series A Preferred Stock dividend payment date, in which case no additional amount for any accrued and unpaid dividend that will be paid on such dividend payment date will be included in this sum) by (ii) the common stock price (as defined in the Articles Supplementary); and
	•	1.7864 (the share cap), subject to certain adjustments;
	subject, in each case, to provisions for the receipt of alternative consideration as described in the Articles Supplementary governing the Series A Preferred Stock.
	Upon issuance of the Series A Preferred Stock, the Company classified the par value as preferred equity on its condensed consolidated balance sheets with the balance of the liquidation preference, net of any issuance costs, recorded as an increase in paid-in capital.
	Common Stock
	The following table lists the cash dividends on common stock declared and paid by the Company during the three months ended March 31, 2014:
	Declaration Date		Record Date	Amount Per Share		Dividend Payable Date
	23-Jan-14		15-Feb-14	$	0.36	28-Feb-14
	During the three months ended March 31, 2014, the Company issued 175,096 shares of common stock as a result of restricted stock unit vestings and in connection with amounts payable under the Company's 2013 Bonus Plan pursuant to an election by certain participants to receive the bonus payment in shares of the Company's common stock. During the three months ended March 31, 2014, the Company issued 11,515 shares of common stock as a result of stock options exercised.
	Upon any payment of shares as a result of restricted stock unit vestings, the participant is required to satisfy the related tax withholding obligation. The 2009 Performance Incentive Plan provides that the Company has the right at its option to (a) require the participant to pay such tax withholding or (b) reduce the number of shares to be delivered by a number of shares necessary to satisfy the related minimum applicable statutory tax withholding obligation. During the three months ended March 31, 2014, pursuant to advance elections made by certain participants, the Company paid $5.1 million in tax withholding obligations that were satisfied through a reduction in the number of shares delivered to those participants.
	At-The-Market Common Stock Offering Program (“ATM Program”)
	On March 18, 2013, the Company entered into a sales agreement (each, a “Sales Agreement”) with each of Barclays Capital Inc., Cantor Fitzgerald & Co., Credit Agricole Securities (USA) Inc., RBC Capital Markets, LLC, RBS Securities Inc. and Wells Fargo Securities, LLC (individually, a “Sales Agent” and together, the “Sales Agents”) to sell shares of its common stock having aggregate gross proceeds of up to $100.0 million (the “ATM Shares”) from time to time through the Sales Agents.
	Pursuant to the terms of the Sales Agreements, the ATM Shares may be sold by any method permitted by law deemed to be an “at-the-market” offering, including, without limitation, sales made directly on the NASDAQ Global Select Market, on any other existing trading market for the Company's common stock or to or through a market maker. In addition, with the Company's prior consent, the Sales Agents may also sell the ATM Shares in privately negotiated transactions. The Company will pay each Sales Agent a commission of up to 2% of the gross proceeds from the sales of ATM Shares sold pursuant to the applicable Sales Agreement.
	During the three months ended March 31, 2014, the Company sold 0.2 million ATM Shares, at an average price of $27.68 per share, generating gross proceeds of approximately $4.6 million, before $0.1 million of commissions. As of March 31, 2014, the Company had $57.1 million available under the ATM Program.

EARNINGS_PER_COMMON_SHARE

EARNINGS PER COMMON SHARE	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Earnings Per Common Share	'
	EARNINGS PER COMMON SHARE
	The following table illustrates the computation of basic and diluted earnings per share for the three months ended March 31, 2014 and 2013 (in thousands, except share and per share amounts):
		Three Months Ended March 31,
		2014			2013
	Numerator
	Net (loss) income attributable to common stockholders	$	(9,864	)	$	9,253
	Denominator
	Basic weighted average common shares	38,968,403			37,286,121
	Dilutive stock options and restricted stock units	—			453,843
	Diluted weighted average common shares	38,968,403			37,739,964
	Net (loss) income attributable to common stockholders, per:
	Basic common share	$	(0.25	)	$	0.25
	Diluted common share	$	(0.25	)	$	0.25
	Certain of our outstanding restricted stock units are considered participating securities because dividend payments are not forfeited even if the underlying award does not vest. Accordingly, the Company uses the two-class method when computing basic and diluted earnings per share. During the three months ended March 31, 2014 and 2013, 38,000 and 100 restricted stock units, respectively, were not included because they were considered anti-dilutive. No stock options were considered anti-dilutive during the three months ended March 31, 2014 and 2013.

SUMMARIZED_CONDENSED_CONSOLIDA

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION	3 Months Ended
	Mar. 31, 2014
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]	'
Summarized Condensed Consolidating Information	'
	SUMMARIZED CONDENSED CONSOLIDATING INFORMATION
	In connection with the offerings of the Senior Notes by the Issuers and the Issuers’ previous offerings of the 2018 Notes (which were no longer outstanding as of March 31, 2014), the Company and certain 100% owned subsidiaries of the Company (the “Guarantors”) have, jointly and severally, fully and unconditionally guaranteed the Senior Notes, subject to release under certain customary circumstances as described below. These guarantees are subordinated to all existing and future senior debt and senior guarantees of the Guarantors and are unsecured. The Company conducts all of its business through and derives virtually all of its income from its subsidiaries. Therefore, the Company’s ability to make required payments with respect to its indebtedness (including the Senior Notes) and other obligations depends on the financial results and condition of its subsidiaries and its ability to receive funds from its subsidiaries.
	A Guarantor will be automatically and unconditionally released from its obligations under the guarantees with respect to the Senior Notes in the event of:
	•	Any sale of the subsidiary Guarantor or of all or substantially all of its assets;
	•	A merger or consolidation of a subsidiary Guarantor with an issuer of the Senior Notes or another Guarantor, provided that the surviving entity remains a Guarantor;
	•	A subsidiary Guarantor is declared “unrestricted” for covenant purposes under the Senior Notes Indentures;
	•	The requirements for legal defeasance or covenant defeasance or to discharge the Senior Notes Indentures have been satisfied;
	•	A liquidation or dissolution, to the extent permitted under the Senior Notes Indentures, of a subsidiary Guarantor; and
	•	The release or discharge of the guaranty that resulted in the creation of the subsidiary guaranty, except a discharge or release by or as a result of payment under such guaranty.
	Pursuant to Rule 3-10 of Regulation S-X, the following summarized condensed consolidating information is provided for the Company (the “Parent Company”), the Issuers, the Guarantors, and the Company’s non-Guarantor subsidiaries with respect to the Senior Notes. This summarized financial information has been prepared from the books and records maintained by the Company, the Issuers, the Guarantors and the non-Guarantor subsidiaries. The summarized financial information may not necessarily be indicative of the results of operations or financial position had the Issuers, the Guarantors or non-Guarantor subsidiaries operated as independent entities. Sabra’s investments in its consolidated subsidiaries are presented based upon Sabra's proportionate share of each subsidiary's net assets. The Guarantor subsidiaries’ investments in the non-Guarantor subsidiaries and non-Guarantor subsidiaries’ investments in Guarantor subsidiaries are presented under the equity method of accounting. Intercompany activities between subsidiaries and the Parent Company are presented within operating activities on the condensed consolidating statement of cash flows.
	Condensed consolidating financial statements for the Company and its subsidiaries, including the Parent Company only, the Issuers, the combined Guarantor subsidiaries and the combined non-Guarantor subsidiaries, are as follows:
	CONDENSED CONSOLIDATING BALANCE SHEET
	March 31, 2014
	(dollars in thousands, except per share amounts)
	(unaudited)
		Parent			Issuers			Combined			Combined Non-				Elimination				Consolidated
		Company						Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	88		$	—		$	850,923		$	170,693			$	—			$	1,021,704
	Loans receivable and other investments, net	—			—			199,603			—				—				199,603
	Cash and cash equivalents	2,301			—			—			1,985				—				4,286
	Restricted cash	—			—			142			6,222				—				6,364
	Deferred tax assets	24,212			—			—			—				—				24,212
	Prepaid expenses, deferred financing costs and other assets	1,235			13,864			52,618			7,470				—				75,187
	Intercompany	55,099			375,082			—			9,977				(440,158		)		—
	Investment in subsidiaries	385,248			553,523			9,070			—				(947,841		)		—
	Total assets	$	468,183		$	942,469		$	1,112,356		$	196,347			$	(1,387,999	)		$	1,331,356
	Liabilities
	Mortgage notes	$	—		$	—		$	—		$	130,106			$	—			$	130,106
	Secured revolving credit facility	—			—			162,000			—				—				162,000
	Senior unsecured notes	—			550,000			—			—				—				550,000
	Accounts payable and accrued liabilities	5,230			7,221			12,892			972				—				26,315
	Tax liability	24,212			—			—			—				—				24,212
	Intercompany	—			—			440,158			—				(440,158		)		—
	Total liabilities	29,442			557,221			615,050			131,078				(440,158		)		892,633
	Equity
	Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of March 31, 2014	58			—			—			—				—				58
	Common stock, $.01 par value; 125,000,000 shares authorized, 39,143,251 shares issued and outstanding as of March 31, 2014	391			—			—			—				—				391
	Additional paid-in capital	537,288			280,437			309,490			34,325				(624,252		)		537,288
	Cumulative distributions in excess of net income	(98,996		)	104,811			187,816			30,962				(323,589		)		(98,996		)
	Total Sabra Health Care REIT, Inc. stockholders' equity	438,741			385,248			497,306			65,287				(947,841		)		438,741
	Noncontrolling interests	—			—			—			(18		)		—				(18		)
	Total equity	438,741			385,248			497,306			65,269				(947,841		)		438,723
	Total liabilities and equity	$	468,183		$	942,469		$	1,112,356		$	196,347			$	(1,387,999	)		$	1,331,356
	CONDENSED CONSOLIDATING BALANCE SHEET
	December 31, 2013
	(dollars in thousands, except per share amounts)
		Parent			Issuers			Combined			Combined  Non-				Elimination				Consolidated
		Company						Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	101		$	—		$	751,771		$	163,546			$	—			$	915,418
	Loans receivable, net	—			—			185,293			—				—				185,293
	Cash and cash equivalents	3,551			—			—			757				—				4,308
	Restricted cash	—			—			121			5,231				—				5,352
	Deferred tax assets	24,212			—			—			—				—				24,212
	Prepaid expenses, deferred financing costs and other assets	1,217			9,207			46,694			6,134				—				63,252
	Intercompany	63,125			270,194			—			42,637				(375,956		)		—
	Investment in subsidiaries	398,640			537,505			25,205			—				(961,350		)		—
	Total assets	$	490,846		$	816,906		$	1,009,084		$	218,305			$	(1,337,306	)		$	1,197,835
	Liabilities
	Mortgage notes	$	—		$	—		$	—		$	141,328			$	—			$	141,328
Secured revolving credit facility	—			—			135,500			—				—				135,500
Senior unsecured notes	—			414,402			—			—				—				414,402
Accounts payable and accrued liabilities	6,470			3,864			11,008			887				—				22,229
Tax liability	24,212			—			—			—				—				24,212
Intercompany	—			—			375,956			—				(375,956		)		—
Total liabilities	30,682			418,266			522,464			142,215				(375,956		)		737,671
Equity
Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of December 31, 2013	58			—			—			—				—				58
Common stock, $.01 par value; 125,000,000 shares authorized, 38,788,745 shares issued and outstanding as of December 31, 2013	388			—			—			—				—				388
Additional paid-in capital	534,639			291,226			323,574			48,507				(663,307		)		534,639
Cumulative distributions in excess of net income	(74,921		)	107,414			163,046			27,583				(298,043		)		(74,921		)
Total Sabra Health Care REIT, Inc. stockholders' equity	460,164			398,640			486,620			76,090				(961,350		)		460,164
Total liabilities and equity	$	490,846		$	816,906		$	1,009,084		$	218,305			$	(1,337,306	)		$	1,197,835
CONDENSED CONSOLIDATING STATEMENT OF (LOSS) INCOME
For the Three Months Ended March 31, 2014
(dollars in thousands, except per share amounts)
(unaudited)
	Parent Company			Issuers			Combined			Combined Non-				Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Revenues:
Rental income	$	—		$	—		$	28,777		$	7,316			$	—			$	36,093
Interest and other income	4			—			4,092			661				—				4,757
Total revenues	4			—			32,869			7,977				—				40,850
Expenses:
Depreciation and amortization	13			—			7,420			1,917				—				9,350
Interest	—			7,790			1,874			1,470				—				11,134
General and administrative	4,692			1			444			716				—				5,853
Total expenses	4,705			7,791			9,738			4,103				—				26,337
Other (expense) income:
Loss on extinguishment of debt	—			(21,619		)	—			(515		)		—				(22,134		)
Other income	—			—			300			—				—				300
Total other (expense) income	—			(21,619		)	300			(515		)		—				(21,834		)
(Loss) income in subsidiary	(2,602		)	26,808			1,341			—				(25,547		)		—
Net (loss) income	(7,303		)	(2,602		)	24,772			3,359				(25,547		)		(7,321		)
Net loss attributable to noncontrolling interests	—			—			—			18				—				18
Net (loss) income attributable to Sabra Health Care REIT, Inc.	(7,303		)	(2,602		)	24,772			3,377				(25,547		)		(7,303		)
Preferred stock dividends	(2,561		)	—			—			—				—				(2,561		)
Net (loss) income attributable to common stockholders	$	(9,864	)	$	(2,602	)	$	24,772		$	3,377			$	(25,547	)		$	(9,864	)
Net (loss) attributable to common stockholders, per:
Basic common share																		$	(0.25	)
Diluted common share																		$	(0.25	)
Weighted-average number of common shares outstanding, basic																		38,968,403
Weighted-average number of common shares outstanding, diluted																		38,968,403
CONDENSED CONSOLIDATING STATEMENT OF INCOME
For the Three Months Ended March 31, 2013
(dollars in thousands, except per share amounts)
(unaudited)
	Parent Company			Issuers			Combined			Combined Non-				Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Revenues:
Rental income	$	—		$	—		$	24,134		$	7,341			$	—			$	31,475
Interest and other income	54			—			493			—				—				547
Total revenues	54			—			24,627			7,341				—				32,022
Expenses:
Depreciation and amortization	13			—			6,314			1,919				—				8,246
Interest	—			6,716			1,340			1,946				—				10,002
General and administrative	4,584			1			114			18				—				4,717
Total expenses	4,597			6,717			7,768			3,883				—				22,965
Other income (expense):
Other income	—			—			500			—				—				500
Total other income (expense)	—			—			500			—				—				500
Income in subsidiary	14,100			20,817			980			—				(35,897		)		—
Net income	9,557			14,100			18,339			3,458				(35,897		)		9,557
Preferred dividends	(304		)	—			—			—				—				(304		)
Net income attributable to common stockholders	$	9,253		$	14,100		$	18,339		$	3,458			$	(35,897	)		$	9,253
Net income attributable to common stockholders, per:
Basic common share																		$	0.25
Diluted common share																		$	0.25
Weighted-average number of common shares outstanding, basic																		37,286,121
Weighted-average number of common shares outstanding, diluted																		37,739,964
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Three Months Ended March 31, 2014
(in thousands)
(unaudited)
	Parent Company			Issuers			Combined			Combined  Non-					Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Net cash (used in) provided by operating activities	$	(10,795	)	$	—		$	—		$	12,002				$	—			$	1,207
Cash flows from investing activities:
Acquisitions of real estate	—			—			(108,650		)	—					—				(108,650		)
Origination of note receivable	—			—			(19,428		)	—					—				(19,428		)
Preferred equity investment	—			—			(5		)	—					—				(5		)
Additions to real estate	—			—			(56		)	—					—				(56		)
Investment in Subsidiary	(1,165		)	(1,165		)	—			—					2,330				—
Intercompany financing	27,955			(101,641		)	—			—					73,686				—
Net cash provided by (used in) investing activities	26,790			(102,806		)	(128,139		)	—					76,016				(128,139		)
Cash flows from financing activities:
Proceeds from issuance of senior unsecured notes	—			350,000			—			—			—		—				350,000
Principal payments on senior unsecured notes	—			(211,250		)	—			—					—				(211,250		)
Proceeds from secured revolving credit facility	—			—			50,000			—					—				50,000
Payments on secured revolving credit facility	—			—			(23,500		)	—					—				(23,500		)
Proceeds from mortgage notes	—			—			—			46,103					—				46,103
Principal payments on mortgage notes	—			—			—			(57,325		)			—				(57,325		)
Payments of deferred financing costs	—			(9,154		)	(2		)	(717		)			—				(9,873		)
Issuance of common stock	(648		)	—			—			—					—				(648		)
Dividends paid on common and preferred stock	(16,597		)	—			—			—					—				(16,597		)
Contribution from Parent	—			1,165			—			1,165					(2,330		)		—
Intercompany financing	—			(27,955		)	101,641			—					(73,686		)		—
Net cash (used in) provided by financing activities	(17,245		)	102,806			128,139			(10,774		)			(76,016		)		126,910
Net (decrease) increase in cash and cash equivalents	(1,250		)	—			—			1,228					—				(22		)
Cash and cash equivalents, beginning of period	3,551			—			—			757					—				4,308
Cash and cash equivalents, end of period	$	2,301		$	—		$	—		$	1,985				$	—			$	4,286
CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
For the Three Months Ended March 31, 2013
(in thousands)
(unaudited)
	Parent Company			Issuers			Combined			Combined  Non-				Elimination				Consolidated
							Guarantor			Guarantor
							Subsidiaries			Subsidiaries
Net cash provided by operating activities	$	20,103		$	—		$	—		$	1,500			$	—			$	21,603
Cash flows from investing activities:
Origination of note receivable	—			—			(12,873		)	—				—				(12,873		)
Preferred equity investment	—			—			(4,646		)	—				—				(4,646		)
Net proceeds from the sale of real estate	—			—			—			2,208				—				2,208
Distribution from Subsidiary	1,851			1,851			—			—				(3,702		)		—
Intercompany financing	(107,901		)	(107,886		)	—			—				215,787				—
Net cash (used in) provided by investing activities	(106,050		)	(106,035		)	(17,519		)	2,208				212,085				(15,311		)
Cash flows from financing activities:
Principal payments on secured revolving credit facility	—			—			(92,500		)	—				—				(92,500		)
Principal payments on mortgage notes	—			—			—			(989		)		—				(989		)
Payments of deferred financing costs	—			(15		)	(75		)	18				—				(72		)
Issuance of common stock	(2,534		)	—			—			—				—				(2,534		)
Issuance of preferred stock	138,983			—			—			—				—				138,983
Dividends paid	(12,716		)	—			—			—				—				(12,716		)
Distribution to Parent	—			(1,851		)	—			(1,851		)		3,702				—
Intercompany financing	—			107,901			110,094			(2,208		)		(215,787		)		—
Net cash provided by (used in) financing activities	123,733			106,035			17,519			(5,030		)		(212,085		)		30,172
Net increase (decrease) in cash and cash equivalents	37,786			—			—			(1,322		)		—				36,464
Cash and cash equivalents, beginning of period	15,075			—			—			2,026				—				17,101
Cash and cash equivalents, end of period	$	52,861		$	—		$	—		$	704			$	—			$	53,565

PRO_FORMA_FINANCIAL_INFORMATIO

PRO FORMA FINANCIAL INFORMATION (Notes)	3 Months Ended
	Mar. 31, 2014
PRO FORMA FINANCIAL INFORMATION [Abstract]	'
Pro Forma Financial Information [Text Block]	'
	PRO FORMA FINANCIAL INFORMATION
	The following table summarizes, on an unaudited pro forma basis, the consolidated results of operations of the Company for the three months ended March 31, 2014 and 2013. The Company acquired six skilled nursing facilities and two senior housing facilities during the three months ended March 31, 2014. The following unaudited pro forma information has been prepared to give effect to these acquisitions as if these acquisitions occurred on January 1, 2013. This pro forma information does not purport to represent what the actual results of operations of the Company would have been had this acquisition occurred on this date, nor does it purport to predict the results of operations for future periods (in thousands, except share and per share amounts):
		Three Months Ended March 31,
		2014		2013
	Revenues	42,322		34,733
	Depreciation and amortization	9,702		9,104
	Net (loss) income attributable to common stockholders	(8,467	)	10,829
	Net (loss) income attributable to common stockholders, per:
	Basic common share	(0.22	)	0.29
	Diluted common share	(0.22	)	0.29
	Weighted-average number of common shares outstanding, basic	38,968,403		37,286,121
	Weighted-average number of common shares outstanding, diluted	38,968,403		37,739,964

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosures [Text Block]	'
	COMMITMENTS AND CONTINGENCIES
	Environmental
	As an owner of real estate, the Company is subject to various environmental laws of federal, state and local governments. The Company is not aware of any environmental liability that could have a material adverse effect on its financial condition or results of operations. However, changes in applicable environmental laws and regulations, the uses and conditions of properties in the vicinity of the Company’s properties, the activities of its tenants and other environmental conditions of which the Company is unaware with respect to the properties could result in future environmental liabilities. Compliance with existing environmental laws is not expected to have a material adverse effect on the Company’s financial condition and results of operations as of March 31, 2014.
	Separation and REIT Conversion Merger
	On May 24, 2010, Old Sun announced its intention to restructure its business by separating its real estate assets and its operating assets into two separate publicly traded companies, Sabra and SHG Services Inc. (which was then renamed “Sun Healthcare Group, Inc.” or “Sun”). In order to effect the restructuring, Old Sun distributed to its stockholders on a pro rata basis all of the outstanding shares of common stock of Sun (this distribution is referred to as the “Separation”), together with an additional cash distribution. Immediately following the Separation, Old Sun merged with and into Sabra, with Sabra surviving the merger and Old Sun stockholders receiving shares of Sabra common stock in exchange for their shares of Old Sun common
	stock (this merger is referred to as the “REIT Conversion Merger”). Effective November 15, 2010, the Separation and REIT Conversion Merger were completed and Sabra and Sun began operations as separate companies.
	Following the Separation, Sun, through its subsidiaries, continued the business and operations of Old Sun and its subsidiaries. Sabra did not operate prior to the Separation. Immediately following the Separation, subsidiaries of Sabra owned substantially all of Old Sun’s owned real property. The owned real property held by subsidiaries of Sabra following the Separation includes fixtures and certain personal property associated with the real property. The historical consolidated financial statements of Old Sun became the historical consolidated financial statements of Sun at the time of the Separation. At the time of the Separation, the balance sheet of Sabra included the owned real property and mortgage indebtedness to third parties on the real property as well as indebtedness incurred by Sabra prior to completion of the Separation. The statements of income and cash flows of Sabra consist solely of its operations after the Separation. The Separation was accounted for as a reverse spinoff. Accordingly, Sabra’s assets and liabilities are recorded at the historical carrying values of Old Sun.
	In connection with the Separation and REIT Conversion Merger, any liability arising from or relating to legal proceedings involving the Company’s real estate investments has been assumed by the Company and the Company will indemnify Sun (and its subsidiaries, directors, officers, employees and agents and certain other related parties) against any losses arising from or relating to such legal proceedings. In addition, pursuant to a distribution agreement entered into among Old Sun, the Company and Sun in connection with the Separation and REIT Conversion Merger, Sun has agreed to indemnify the Company (and the Company’s subsidiaries, directors, officers, employees and agents and certain other related parties) for any liability arising from or relating to legal proceedings involving Old Sun’s healthcare business prior to the Separation, and, pursuant to the lease agreements between the Company and subsidiaries of Sun, the tenants agree to indemnify the Company for any liability arising from operations at the real property leased from the Company.
	Immediately prior to the Separation, Old Sun was a party to various legal actions and administrative proceedings, including various claims arising in the ordinary course of its healthcare business, which are subject to the indemnities to be provided by Sun to the Company. While these actions and proceedings are not believed to be material, individually or in the aggregate, the ultimate outcome of these matters cannot be predicted. The resolution of any such legal proceedings, either individually or in the aggregate, could have a material adverse effect on Sun’s business, financial position or results of operations, which, in turn, could have a material adverse effect on the Company’s business, financial position or results of operations if Sun or its subsidiaries are unable to meet their indemnification obligations.
	For income tax purposes, the Company is the surviving taxpayer of the Separation. Accordingly, tax positions taken by Old Sun prior to the Separation remained the Company’s obligations after the Separation. However, under an agreement with Sun relating to tax allocation matters, Sun is responsible for and will indemnify the Company against, among other things, federal, state and local taxes (including penalties and interest) related to periods prior to the Separation to the extent the deferred tax assets allocated to the Company as part of the Separation are not sufficient and/or cannot be utilized to satisfy these taxes. After the 2010 tax year, the Company and Sun have agreed, to the extent allowable by applicable law, to allocate all net operating loss attributes generated in prior years to Sun. In addition, Sun will generally have the right to control the conduct and disposition of any tax audits or other proceedings with regard to such periods, and will be entitled to any refund or credit for such periods.
	Effective December 1, 2012, Sun was acquired by Genesis HealthCare LLC (“Genesis”). As a result of its acquisition of Sun, Genesis became successor to the obligations of Sun described above.
	Legal Matters
	From time to time, the Company is party to legal proceedings that arise in the ordinary course of its business. Management is not aware of any legal proceedings where the likelihood of a loss contingency is reasonably possible and the amount or range of reasonably possible losses is material to the Company's results of operations, financial condition or cash flows.

SUBSEQUENT_EVENTS_Notes

SUBSEQUENT EVENTS (Notes)	3 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	SUBSEQUENT EVENTS
	The Company evaluates subsequent events up until the date the condensed consolidated financial statements are issued.
	Dividend Declaration
	On May 5, 2014, the Company announced that its board of directors declared a quarterly cash dividend of $0.38 per share of common stock. The dividend will be paid on May 30, 2014 to common stockholders of record as of the close of business on May 15, 2014.
	On May 5, 2014, the Company also announced that its board of directors declared a quarterly cash dividend of $0.4453125 per share of Series A Preferred Stock. The dividend will be paid on May 30, 2014 to preferred stockholders of record as of the close of business on May 15, 2014.
	Park Place Acquisition
	On April 29, 2014, the Company acquired a senior housing campus in Fort Wayne, Indiana (“Park Place”) with a total of 140 units (24 independent living units, 76 assisted living units and 40 memory care units) for $23.8 million. Park Place is encumbered by a HUD-insured mortgage with an outstanding principal balance of approximately $14.1 million and an annual interest rate of 4.84%. At closing, $1.1 million of the purchase price was used to repay an interim loan made by the Company to affiliates of the Leo Brown Group, the operator of Park Place, and the Company assumed the $14.1 million HUD-insured mortgage, resulting in a cash investment of $8.6 million.
	Concurrently with the purchase, the Company entered into a triple-net master lease agreement with affiliates of the Leo Brown Group. The lease has an initial term of 15 years with two renewal options of five years each and provides for an annual rent escalator of the greater of (i) Consumer Price Index and (ii) 3.0%, but not to exceed 4.0%, resulting in annual lease revenues, determined in accordance with GAAP, of $2.2 million.
	Mortgage Debt Repayment
	On May 1, 2014, the Company repaid $29.8 million of existing variable rate mortgage indebtedness, having an interest rate of 5.0% per annum as of March 31, 2014, with proceeds from its Revolving Credit Facility.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recently Issued Accounting Standards Update
	On April 10, 2014, the FASB issued Accounting Standards Update No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU No. 2014-08”), which changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. Under the new guidance, a discontinued operation is defined as a disposal of a component or group of components that is disposed of or is classified as held for sale and represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results. The standard no longer precludes presentation as a discontinued operation if (i) there are operations and cash flows of the component that have not been eliminated from the reporting entity’s ongoing operations, or (ii) there is significant continuing involvement with a component after its disposal. ASU No. 2014-08 is effective for public entities for interim and annual periods beginning after December 15, 2014, and will be applied prospectively.  The adoption of this guidance is not expected to have a material impact on the Company's consolidated financial statements.

RECENT_REAL_ESTATE_ACQUISITION1

RECENT REAL ESTATE ACQUISITIONS (Tables)	3 Months Ended
	Mar. 31, 2014
RECENT REAL ESTATE ACQUISITIONS [Abstract]	'
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	'
	The consideration was allocated as follows (in thousands):
					Intangibles
	Land		Building and Improvements		Tenant Origination and Absorption Costs		Tenant Relationship		Total Consideration
	$	9,640	$	105,741	$	1,741	$	586	$	117,708

REAL_ESTATE_INVESTMENTS_Tables

REAL ESTATE INVESTMENTS (Tables)	3 Months Ended
	Mar. 31, 2014
Real Estate Investments, Net [Abstract]	'
Schedule of Real Estate Properties	'
	REAL ESTATE PROPERTIES HELD FOR INVESTMENT
	The Company’s real estate properties held for investment consisted of the following (dollars in thousands):
	As of March 31, 2014
	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Post-Acute		102		11,460			$	824,328	$	(138,529	)	$	685,799
	Senior Housing		25		1,826			181,544		(14,563		)	166,981
	Acute Care Hospitals		2		124			175,807		(6,971		)	168,836
			129		13,410			1,181,679		(160,063		)	1,021,616
	Corporate Level							254		(166		)	88
								$	1,181,933	$	(160,229	)	$	1,021,704
	As of December 31, 2013
	Property Type		Number of		Number of			Total		Accumulated			Total
			Properties		Beds/Units			Real Estate		Depreciation			Real Estate
								at Cost					Investments, Net
	Skilled Nursing/Post-Acute		96		10,826			$	737,188	$	(132,068	)	$	605,120
	Senior Housing		23		1,518			153,247		(13,337		)	139,910
	Acute Care Hospitals		2		124			175,807		(5,520		)	170,287
			121		12,468			1,066,242		(150,925		)	915,317
	Corporate Level							254		(153		)	101
								$	1,066,496	$	(151,078	)	$	915,418
		March 31, 2014			December 31, 2013
	Building and improvements	$	979,097		$	879,926
	Furniture and equipment	57,193			50,567
	Land improvements	4,392			4,392
	Land	141,251			131,611
		1,181,933			1,066,496
	Accumulated depreciation	(160,229		)	(151,078		)
		$	1,021,704		$	915,418
Schedule of Future Minimum Rental Payments Receivable for Operating Leases	'
	As of March 31, 2014, the future minimum rental payments from the Company’s properties under non-cancelable operating leases was as follows (in thousands):
	April 1, 2014 through December 31, 2014	$	101,053
	2015	138,355
	2016	141,204
	2017	144,746
	2018	148,382
	Thereafter	965,518
		$	1,639,258

LOANS_RECEIVABLE_AND_OTHER_INV1

LOANS RECEIVABLE AND OTHER INVESTMENTS (Tables)	3 Months Ended
	Mar. 31, 2014
Loans Receivable and Other Investments [Abstract]	'
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]	'
	As of March 31, 2014, the Company’s loans receivable and other investments consisted of the following (dollars in thousands):
	Investment	Quantity	Facility Type	Principal Balance as of March 31, 2014		Book Value as of March 31, 2014		Weighted Average Contractual Rate		Weighted Average Annualized Effective Rate		Maturity Date
	Loans Receivable:
	Mortgage	4	Skilled Nursing / Senior Housing / Acute Care Hospital	$	149,161	$	149,648	8.2	%	8.1	%	10/31/16 - 1/31/18
	Construction	3	Acute Care Hospital / Memory Care	33,044		33,375		7.5	%	7.4	%	9/30/16 - 10/31/18
	Mezzanine	1	Skilled Nursing	6,517		6,541		12	%	11.6	%	12/27/14
	Pre-development	3	Senior Housing	1,884		1,965		9	%	7.8	%	8/16/15 - 1/28/17
		11		190,606		191,529		8.2	%	8.1	%
	Other Investments:
	Preferred Equity	2	Skilled Nursing / Memory Care	7,979		8,074		15	%	15	%	NA
	Total	13		$	198,585	$	199,603	8.5	%	8.4	%

DEBT_Tables

DEBT (Tables)	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Schedule of Mortgage Indebtness	'
	The Company’s mortgage notes payable consisted of the following (dollars in thousands):
	Interest Rate Type	Book Value as of			Book Value as of			Weighted Average			Maturity
		31-Mar-14			December 31, 2013			Effective Interest Rate at			Date
								31-Mar-14
	Fixed Rate	$	100,335		$	54,688		3.66	%		May 2031 - June 2047
	Variable Rate(1)	29,771			86,640			5	%		Aug-15
		$	130,106		$	141,328		3.97	%
	(1) Contractual interest rates under variable rate mortgages are equal to the 90-day LIBOR plus 4.0% (subject to a 1.0% LIBOR floor).
Schedule of Maturities of Debt	'
	The following is a schedule of maturities for the Company’s outstanding debt as of March 31, 2014 (in thousands):
			Mortgage			Senior Notes			Revolving Credit Facility (1)			Total
			Indebtedness
	April 1, 2014 through December 31, 2014		$	2,416		$	—		$	—		$	2,416
	2015		31,637			—			—			31,637
	2016		2,553			—			162,000			164,553
	2017		2,634			—			—			2,634
	2018		2,717			—			—			2,717
	Thereafter		88,149			550,000			—			638,149
			$	130,106		$	550,000		$	162,000		$	842,106
	(1) Subject to a one-year extension option.

FAIR_VALUE_DISCLOSURES_Tables

FAIR VALUE DISCLOSURES (Tables)	3 Months Ended
	Mar. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair Value, by Balance Sheet Grouping	'
	The following are the face values, carrying amounts and fair values of the Company’s financial instruments as of March 31, 2014 and December 31, 2013 whose carrying amounts do not approximate their fair value (in thousands):
		March 31, 2014								December 31, 2013
		Face				Carrying		Fair		Face		Carrying		Fair
		Value (1)				Amount (2)		Value		Value (1)		Amount (2)		Value
	Financial assets:
	Loans receivable	$	190,606			$	191,529	$	193,069	$	176,558	$	177,509	$	176,985
	Preferred equity investments	7,979				8,074		8,236		7,695		7,784		7,950
	Financial liabilities:
	Senior Notes	550,000				550,000		566,875		411,250		414,402		421,122
	Mortgage indebtedness	130,106				130,106		121,208		141,328		141,328		130,622
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	'
	During the three months ended March 31, 2014, the Company recorded the following amounts measured at fair value (in thousands):
						Fair Value Measurements Using
						Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
		Total				(Level 1)		(Level 2)		(Level 3)
	Recurring Basis:
	Contingent consideration	$	10,400			$	—	$	—	$	10,400
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	'
	Balance as of December 31, 2013		$	7,500
	New contingent liability		3,200
	Decrease in contingent liability		(300		)
	Balance as of March 31, 2014		$	10,400
Recurring [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair Value Measurements, Recurring and Nonrecurring	'
	The Company determined the fair value of financial instruments as of March 31, 2014 whose carrying amounts do not approximate their fair value with valuation methods utilizing the following types of inputs (in thousands):
						Fair Value Measurements Using
						Quoted Prices in Active Markets for Identical Assets		Significant Other Observable Inputs		Significant Unobservable Inputs
		Total				(Level 1)		(Level 2)		(Level 3)
	Financial assets:
	Loans receivable	$	193,069			$	—	$	—	$	193,069
	Preferred equity investments	8,236				—		—		8,236
	Financial liabilities:
	Senior Notes	566,875				—		566,875		—
	Mortgage indebtedness	121,208				—		—		121,208

EQUITY_Tables

EQUITY (Tables)	3 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Schedule of Dividends Paid	'
	The following table lists the cash dividends on common stock declared and paid by the Company during the three months ended March 31, 2014:
	Declaration Date	Record Date	Amount Per Share		Dividend Payable Date
	23-Jan-14	15-Feb-14	$	0.36	28-Feb-14

EARNINGS_PER_COMMON_SHARE_Tabl

EARNINGS PER COMMON SHARE (Tables)	3 Months Ended
	Mar. 31, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted	'
	The following table illustrates the computation of basic and diluted earnings per share for the three months ended March 31, 2014 and 2013 (in thousands, except share and per share amounts):
		Three Months Ended March 31,
		2014			2013
	Numerator
	Net (loss) income attributable to common stockholders	$	(9,864	)	$	9,253
	Denominator
	Basic weighted average common shares	38,968,403			37,286,121
	Dilutive stock options and restricted stock units	—			453,843
	Diluted weighted average common shares	38,968,403			37,739,964
	Net (loss) income attributable to common stockholders, per:
	Basic common share	$	(0.25	)	$	0.25
	Diluted common share	$	(0.25	)	$	0.25

SUMMARIZED_CONDENSED_CONSOLIDA1

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2014
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION [Abstract]	'
Schedule of Condensed Balance Sheet	'
	CONDENSED CONSOLIDATING BALANCE SHEET
	March 31, 2014
	(dollars in thousands, except per share amounts)
	(unaudited)
		Parent			Issuers			Combined			Combined Non-				Elimination				Consolidated
		Company						Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	88		$	—		$	850,923		$	170,693			$	—			$	1,021,704
	Loans receivable and other investments, net	—			—			199,603			—				—				199,603
	Cash and cash equivalents	2,301			—			—			1,985				—				4,286
	Restricted cash	—			—			142			6,222				—				6,364
	Deferred tax assets	24,212			—			—			—				—				24,212
	Prepaid expenses, deferred financing costs and other assets	1,235			13,864			52,618			7,470				—				75,187
	Intercompany	55,099			375,082			—			9,977				(440,158		)		—
	Investment in subsidiaries	385,248			553,523			9,070			—				(947,841		)		—
	Total assets	$	468,183		$	942,469		$	1,112,356		$	196,347			$	(1,387,999	)		$	1,331,356
	Liabilities
	Mortgage notes	$	—		$	—		$	—		$	130,106			$	—			$	130,106
	Secured revolving credit facility	—			—			162,000			—				—				162,000
	Senior unsecured notes	—			550,000			—			—				—				550,000
	Accounts payable and accrued liabilities	5,230			7,221			12,892			972				—				26,315
	Tax liability	24,212			—			—			—				—				24,212
	Intercompany	—			—			440,158			—				(440,158		)		—
	Total liabilities	29,442			557,221			615,050			131,078				(440,158		)		892,633
	Equity
	Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of March 31, 2014	58			—			—			—				—				58
	Common stock, $.01 par value; 125,000,000 shares authorized, 39,143,251 shares issued and outstanding as of March 31, 2014	391			—			—			—				—				391
	Additional paid-in capital	537,288			280,437			309,490			34,325				(624,252		)		537,288
	Cumulative distributions in excess of net income	(98,996		)	104,811			187,816			30,962				(323,589		)		(98,996		)
	Total Sabra Health Care REIT, Inc. stockholders' equity	438,741			385,248			497,306			65,287				(947,841		)		438,741
	Noncontrolling interests	—			—			—			(18		)		—				(18		)
	Total equity	438,741			385,248			497,306			65,269				(947,841		)		438,723
	Total liabilities and equity	$	468,183		$	942,469		$	1,112,356		$	196,347			$	(1,387,999	)		$	1,331,356
	CONDENSED CONSOLIDATING BALANCE SHEET
	December 31, 2013
	(dollars in thousands, except per share amounts)
		Parent			Issuers			Combined			Combined  Non-				Elimination				Consolidated
		Company						Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Assets
	Real estate investments, net of accumulated depreciation	$	101		$	—		$	751,771		$	163,546			$	—			$	915,418
	Loans receivable, net	—			—			185,293			—				—				185,293
	Cash and cash equivalents	3,551			—			—			757				—				4,308
	Restricted cash	—			—			121			5,231				—				5,352
	Deferred tax assets	24,212			—			—			—				—				24,212
	Prepaid expenses, deferred financing costs and other assets	1,217			9,207			46,694			6,134				—				63,252
	Intercompany	63,125			270,194			—			42,637				(375,956		)		—
	Investment in subsidiaries	398,640			537,505			25,205			—				(961,350		)		—
	Total assets	$	490,846		$	816,906		$	1,009,084		$	218,305			$	(1,337,306	)		$	1,197,835
	Liabilities
	Mortgage notes	$	—		$	—		$	—		$	141,328			$	—			$	141,328
	Secured revolving credit facility	—			—			135,500			—				—				135,500
	Senior unsecured notes	—			414,402			—			—				—				414,402
	Accounts payable and accrued liabilities	6,470			3,864			11,008			887				—				22,229
	Tax liability	24,212			—			—			—				—				24,212
	Intercompany	—			—			375,956			—				(375,956		)		—
	Total liabilities	30,682			418,266			522,464			142,215				(375,956		)		737,671
	Equity
	Preferred stock, $.01 par value; 10,000,000 shares authorized, 5,750,000 shares issued and outstanding as of December 31, 2013	58			—			—			—				—				58
	Common stock, $.01 par value; 125,000,000 shares authorized, 38,788,745 shares issued and outstanding as of December 31, 2013	388			—			—			—				—				388
	Additional paid-in capital	534,639			291,226			323,574			48,507				(663,307		)		534,639
	Cumulative distributions in excess of net income	(74,921		)	107,414			163,046			27,583				(298,043		)		(74,921		)
Total Sabra Health Care REIT, Inc. stockholders' equity	460,164			398,640			486,620			76,090				(961,350		)		460,164
Total liabilities and equity	$	490,846		$	816,906		$	1,009,084		$	218,305			$	(1,337,306	)		$	1,197,835
Schedule of Condensed Income Statement	'
	CONDENSED CONSOLIDATING STATEMENT OF (LOSS) INCOME
	For the Three Months Ended March 31, 2014
	(dollars in thousands, except per share amounts)
	(unaudited)
		Parent Company			Issuers			Combined			Combined Non-				Elimination				Consolidated
								Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Revenues:
	Rental income	$	—		$	—		$	28,777		$	7,316			$	—			$	36,093
	Interest and other income	4			—			4,092			661				—				4,757
	Total revenues	4			—			32,869			7,977				—				40,850
	Expenses:
	Depreciation and amortization	13			—			7,420			1,917				—				9,350
	Interest	—			7,790			1,874			1,470				—				11,134
	General and administrative	4,692			1			444			716				—				5,853
	Total expenses	4,705			7,791			9,738			4,103				—				26,337
	Other (expense) income:
	Loss on extinguishment of debt	—			(21,619		)	—			(515		)		—				(22,134		)
	Other income	—			—			300			—				—				300
	Total other (expense) income	—			(21,619		)	300			(515		)		—				(21,834		)
	(Loss) income in subsidiary	(2,602		)	26,808			1,341			—				(25,547		)		—
	Net (loss) income	(7,303		)	(2,602		)	24,772			3,359				(25,547		)		(7,321		)
	Net loss attributable to noncontrolling interests	—			—			—			18				—				18
	Net (loss) income attributable to Sabra Health Care REIT, Inc.	(7,303		)	(2,602		)	24,772			3,377				(25,547		)		(7,303		)
	Preferred stock dividends	(2,561		)	—			—			—				—				(2,561		)
	Net (loss) income attributable to common stockholders	$	(9,864	)	$	(2,602	)	$	24,772		$	3,377			$	(25,547	)		$	(9,864	)
	Net (loss) attributable to common stockholders, per:
	Basic common share																		$	(0.25	)
	Diluted common share																		$	(0.25	)
	Weighted-average number of common shares outstanding, basic																		38,968,403
	Weighted-average number of common shares outstanding, diluted																		38,968,403
	CONDENSED CONSOLIDATING STATEMENT OF INCOME
	For the Three Months Ended March 31, 2013
	(dollars in thousands, except per share amounts)
	(unaudited)
		Parent Company			Issuers			Combined			Combined Non-				Elimination				Consolidated
								Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Revenues:
	Rental income	$	—		$	—		$	24,134		$	7,341			$	—			$	31,475
	Interest and other income	54			—			493			—				—				547
	Total revenues	54			—			24,627			7,341				—				32,022
	Expenses:
	Depreciation and amortization	13			—			6,314			1,919				—				8,246
	Interest	—			6,716			1,340			1,946				—				10,002
	General and administrative	4,584			1			114			18				—				4,717
	Total expenses	4,597			6,717			7,768			3,883				—				22,965
	Other income (expense):
	Other income	—			—			500			—				—				500
	Total other income (expense)	—			—			500			—				—				500
	Income in subsidiary	14,100			20,817			980			—				(35,897		)		—
	Net income	9,557			14,100			18,339			3,458				(35,897		)		9,557
	Preferred dividends	(304		)	—			—			—				—				(304		)
	Net income attributable to common stockholders	$	9,253		$	14,100		$	18,339		$	3,458			$	(35,897	)		$	9,253
	Net income attributable to common stockholders, per:
	Basic common share																		$	0.25
	Diluted common share																		$	0.25
	Weighted-average number of common shares outstanding, basic																		37,286,121
	Weighted-average number of common shares outstanding, diluted																		37,739,964
Schedule of Condensed Cash Flow Statement	'
	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
	For the Three Months Ended March 31, 2014
	(in thousands)
	(unaudited)
		Parent Company			Issuers			Combined			Combined  Non-					Elimination				Consolidated
								Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Net cash (used in) provided by operating activities	$	(10,795	)	$	—		$	—		$	12,002				$	—			$	1,207
	Cash flows from investing activities:
	Acquisitions of real estate	—			—			(108,650		)	—					—				(108,650		)
	Origination of note receivable	—			—			(19,428		)	—					—				(19,428		)
	Preferred equity investment	—			—			(5		)	—					—				(5		)
	Additions to real estate	—			—			(56		)	—					—				(56		)
	Investment in Subsidiary	(1,165		)	(1,165		)	—			—					2,330				—
	Intercompany financing	27,955			(101,641		)	—			—					73,686				—
	Net cash provided by (used in) investing activities	26,790			(102,806		)	(128,139		)	—					76,016				(128,139		)
	Cash flows from financing activities:
	Proceeds from issuance of senior unsecured notes	—			350,000			—			—			—		—				350,000
	Principal payments on senior unsecured notes	—			(211,250		)	—			—					—				(211,250		)
	Proceeds from secured revolving credit facility	—			—			50,000			—					—				50,000
	Payments on secured revolving credit facility	—			—			(23,500		)	—					—				(23,500		)
	Proceeds from mortgage notes	—			—			—			46,103					—				46,103
	Principal payments on mortgage notes	—			—			—			(57,325		)			—				(57,325		)
	Payments of deferred financing costs	—			(9,154		)	(2		)	(717		)			—				(9,873		)
	Issuance of common stock	(648		)	—			—			—					—				(648		)
	Dividends paid on common and preferred stock	(16,597		)	—			—			—					—				(16,597		)
	Contribution from Parent	—			1,165			—			1,165					(2,330		)		—
	Intercompany financing	—			(27,955		)	101,641			—					(73,686		)		—
	Net cash (used in) provided by financing activities	(17,245		)	102,806			128,139			(10,774		)			(76,016		)		126,910
	Net (decrease) increase in cash and cash equivalents	(1,250		)	—			—			1,228					—				(22		)
	Cash and cash equivalents, beginning of period	3,551			—			—			757					—				4,308
	Cash and cash equivalents, end of period	$	2,301		$	—		$	—		$	1,985				$	—			$	4,286
	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS
	For the Three Months Ended March 31, 2013
	(in thousands)
	(unaudited)
		Parent Company			Issuers			Combined			Combined  Non-				Elimination				Consolidated
								Guarantor			Guarantor
								Subsidiaries			Subsidiaries
	Net cash provided by operating activities	$	20,103		$	—		$	—		$	1,500			$	—			$	21,603
	Cash flows from investing activities:
	Origination of note receivable	—			—			(12,873		)	—				—				(12,873		)
	Preferred equity investment	—			—			(4,646		)	—				—				(4,646		)
	Net proceeds from the sale of real estate	—			—			—			2,208				—				2,208
	Distribution from Subsidiary	1,851			1,851			—			—				(3,702		)		—
	Intercompany financing	(107,901		)	(107,886		)	—			—				215,787				—
	Net cash (used in) provided by investing activities	(106,050		)	(106,035		)	(17,519		)	2,208				212,085				(15,311		)
	Cash flows from financing activities:
	Principal payments on secured revolving credit facility	—			—			(92,500		)	—				—				(92,500		)
	Principal payments on mortgage notes	—			—			—			(989		)		—				(989		)
	Payments of deferred financing costs	—			(15		)	(75		)	18				—				(72		)
	Issuance of common stock	(2,534		)	—			—			—				—				(2,534		)
	Issuance of preferred stock	138,983			—			—			—				—				138,983
	Dividends paid	(12,716		)	—			—			—				—				(12,716		)
	Distribution to Parent	—			(1,851		)	—			(1,851		)		3,702				—
	Intercompany financing	—			107,901			110,094			(2,208		)		(215,787		)		—
	Net cash provided by (used in) financing activities	123,733			106,035			17,519			(5,030		)		(212,085		)		30,172
	Net increase (decrease) in cash and cash equivalents	37,786			—			—			(1,322		)		—				36,464
	Cash and cash equivalents, beginning of period	15,075			—			—			2,026				—				17,101
	Cash and cash equivalents, end of period	$	52,861		$	—		$	—		$	704			$	—			$	53,565

PRO_FORMA_FINANCIAL_INFORMATIO1

PRO FORMA FINANCIAL INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2014
PRO FORMA FINANCIAL INFORMATION [Abstract]	'
Business Acquisition, Pro Forma Information [Table Text Block]	'
	This pro forma information does not purport to represent what the actual results of operations of the Company would have been had this acquisition occurred on this date, nor does it purport to predict the results of operations for future periods (in thousands, except share and per share amounts):
		Three Months Ended March 31,
		2014		2013
	Revenues	42,322		34,733
	Depreciation and amortization	9,702		9,104
	Net (loss) income attributable to common stockholders	(8,467	)	10,829
	Net (loss) income attributable to common stockholders, per:
	Basic common share	(0.22	)	0.29
	Diluted common share	(0.22	)	0.29
	Weighted-average number of common shares outstanding, basic	38,968,403		37,286,121
	Weighted-average number of common shares outstanding, diluted	38,968,403		37,739,964

BUSINESS_Details

BUSINESS (Details)

3 Months Ended

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Facilities

Operating Segments [Member]

Operating Segments [Member]

Skilled Nursing/Post-Acute Facilities [Member]

Skilled Nursing/Post-Acute Facilities [Member]

Senior Housing Facilities [Member]

Senior Housing Facilities [Member]

Acute Care Hospital [Member]

Acute Care Hospital [Member]

Construction Mortgage Loans [Member]

Mezzanine Investments [Member]

Pre-Development Loans [Member]

Investment

Facilities

Facilities

Facilities

Facilities

Facilities

Facilities

Facilities

Facilities

Facilities

loan

loan

Real Estate Properties [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Number of Real Estate Properties

'

129

121

102

96

25

23

2

2

'

'

'

Loans and Leases Receivable

'

'

'

'

'

'

'

'

'

'

'

'

Loans and Leases Receivable, Number of Loans

11

'

'

'

'

'

'

'

'

3

1

3

Preferred Equity Investments, Number

2

'

'

'

'

'

'

'

'

'

'

'

Number of Real Estate Properties Leased to Third Party

1

'

'

'

'

'

'

'

'

'

'

'

Ownership Percentage in Real Estate

100.00%

'

'

'

'

'

'

'

'

'

'

'

Third Party Joint Venture Percentage

50.00%

'

'

'

'

'

'

'

'

'

'

'

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Variable Interest Entity [Line Items]	'	'
Real Estate Investment Property, Net	$1,021,704	$915,418
Variable Interest Entity, Primary Beneficiary [Member]	'	'
Variable Interest Entity [Line Items]	'	'
Number of Beds in Real Estate Facility	60	'
Real Estate Investment Property, Net	$9,000	$9,100

RECENT_REAL_ESTATE_ACQUISITION2

RECENT REAL ESTATE ACQUISITIONS (Details) (USD $)	3 Months Ended			0 Months Ended		3 Months Ended			0 Months Ended	3 Months Ended	0 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Feb. 14, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Feb. 14, 2014	Mar. 31, 2014	Feb. 14, 2014
			Series of Individually Immaterial Business Acquisitions [Member]	Nye Portfolio [Member]	Nye Portfolio [Member]	Tenant Origination and Absorption Costs [Member]	Tenant Relationship [Member]	Skilled Nursing/Post-Acute Facilities [Member]	Skilled Nursing/Post-Acute Facilities [Member]	Senior Housing Facilities [Member]	Senior Housing Facilities [Member]
						Series of Individually Immaterial Business Acquisitions [Member]	Series of Individually Immaterial Business Acquisitions [Member]	Series of Individually Immaterial Business Acquisitions [Member]	Nye Portfolio [Member]	Series of Individually Immaterial Business Acquisitions [Member]	Nye Portfolio [Member]
								Facilities	Facilities	Facilities	Facilities
Business Acquisition [Line Items]	'	'	'	'	'	'	'	'	'	'	'
Number of acquired properties	'	'	'	'	'	'	'	6	4	2	2
Purchase price	'	'	$117,700,000	'	'	'	'	'	'	'	'
Recognized Identifiable Assets Acquired	'	'	'	'	'	'	'	'	'	'	'
Land	'	'	9,640,000	'	'	'	'	'	'	'	'
Building and Improvements	'	'	105,741,000	'	'	'	'	'	'	'	'
Intangibles	'	'	'	'	'	1,741,000	586,000	'	'	'	'
Recognized Identifiable Assets Acquired	'	'	117,708,000	'	'	'	'	'	'	'	'
Acquired finite-lived intangible assets, weighted average useful life	'	'	'	'	'	'11 years	'21 years	'	'	'	'
Revenues	40,850,000	32,022,000	1,200,000	'	'	'	'	'	'	'	'
Net Income (Loss) Attributable to Parent	-7,303,000	9,557,000	500,000	'	'	'	'	'	'	'	'
Payments to Acquire Businesses, Gross	'	'	'	90,000,000	'	'	'	'	'	'	'
Contingent consideration liability	'	'	'	$3,200,000	$3,200,000	'	'	'	'	'	'

REAL_ESTATE_INVESTMENTS_Detail

REAL ESTATE INVESTMENTS (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Real Estate Properties [Line Items]	'	'
Buildings and improvements	$979,097	$879,926
Fixtures and equipment	57,193	50,567
Land improvements	4,392	4,392
Land	141,251	131,611
Total Real Estate at Cost	1,181,933	1,066,496
Accumulated Depreciation	-160,229	-151,078
Total Real Estate Investments, Net	1,021,704	915,418
Operating Segments [Member]	'	'
Real Estate Properties [Line Items]	'	'
Number of Properties	129	121
Number of Beds/Units	13,410	12,468
Total Real Estate at Cost	1,181,679	1,066,242
Accumulated Depreciation	-160,063	-150,925
Total Real Estate Investments, Net	1,021,616	915,317
Skilled Nursing/Post-Acute Facilities [Member]	'	'
Real Estate Properties [Line Items]	'	'
Number of Properties	102	96
Number of Beds/Units	11,460	10,826
Total Real Estate at Cost	824,328	737,188
Accumulated Depreciation	-138,529	-132,068
Total Real Estate Investments, Net	685,799	605,120
Senior Housing [Member]	'	'
Real Estate Properties [Line Items]	'	'
Number of Properties	25	23
Number of Beds/Units	1,826	1,518
Total Real Estate at Cost	181,544	153,247
Accumulated Depreciation	-14,563	-13,337
Total Real Estate Investments, Net	166,981	139,910
Acute Care Hospital [Member]	'	'
Real Estate Properties [Line Items]	'	'
Number of Properties	2	2
Number of Beds/Units	124	124
Total Real Estate at Cost	175,807	175,807
Accumulated Depreciation	-6,971	-5,520
Total Real Estate Investments, Net	168,836	170,287
Corporate [Member]	'	'
Real Estate Properties [Line Items]	'	'
Total Real Estate at Cost	254	254
Accumulated Depreciation	-166	-153
Total Real Estate Investments, Net	$88	$101

REAL_ESTATE_INVESTMENTS_Earn_O

REAL ESTATE INVESTMENTS Earn Out (Details) (USD $)	3 Months Ended		0 Months Ended	3 Months Ended					1 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Oct. 22, 2013	Mar. 31, 2014	Apr. 29, 2014	Apr. 29, 2014	Apr. 29, 2014	Apr. 29, 2014	5-May-14
			Forest Park Medical Center - Frisco [Member]	Forest Park Medical Center - Frisco [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]
			Beds		independent_living_unit	assisted_living_unit	memory_care_unit	unit	Forest Park Medical Center - Frisco [Member]
Real Estate Properties [Line Items]	'	'	'	'	'	'	'	'	'
Number of Beds/Units	'	'	54	'	24	76	40	140	'
Purchase price	'	'	$119,800,000	'	'	'	'	'	'
Contingent consideration liability	'	'	7,300,000	7,200,000	'	'	'	'	'
Deposits Assets	'	'	'	10,500,000	'	'	'	'	5,200,000
Change in fair value of contingent consideration	-300,000	-500,000	'	300,000	'	'	'	'	'
Business Combination, Consideration Transferred, Other	'	'	10,500,000	'	'	'	'	'	'
Business Combination, Consideration Transferred, Other, Holding Period	'	'	'20 months	'	'	'	'	'	'
Business Combination, Consideration Transferred, Other, Annual Fee during Holding Period	'	'	500,000	'	'	'	'	'	'
Release of funds from escrow	'	'	'	'	'	'	'	'	$5,300,000

REAL_ESTATE_INVESTMENTS_Operat

REAL ESTATE INVESTMENTS Operating Lease (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014
			Minimum [Member]	Maximum [Member]	Operating Segments [Member]	Operating Segments [Member]	Operating Segments [Member]
					Facilities	Facilities	Genesis Healthcare, Inc [Member]
							Facilities
Property Subject to or Available for Operating Lease [Line Items]	'	'	'	'	'	'	'
Security Deposit Liability	$1,700,000	$1,600,000	'	'	'	'	'
Operating Leases, Lease Expiration Period	'	'	'7 years	'21 years	'	'	'
Operating Leases, Weighted Average Lease Expiration Period	'11 years	'	'	'	'	'	'
Number of Real Estate Properties	'	'	'	'	129	121	81
Operating Leases, Future Minimum Payments Receivable [Abstract]	'	'	'	'	'	'	'
April 1, 2014 through December 31, 2014	101,053,000	'	'	'	'	'	'
2015	138,355,000	'	'	'	'	'	'
2016	141,204,000	'	'	'	'	'	'
2017	144,746,000	'	'	'	'	'	'
2018	148,382,000	'	'	'	'	'	'
Thereafter	965,518,000	'	'	'	'	'	'
Total	$1,639,258,000	'	'	'	'	'	'

LOANS_RECEIVABLE_AND_OTHER_INV2

LOANS RECEIVABLE AND OTHER INVESTMENTS (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 05, 2014	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
	Facilities	Investment		Mortgage Loans Receivable [Member]	Construction Mortgage Loans [Member]	Mezzanine Investments [Member]	Mezzanine Investments [Member]	Chai Mezzanine Loan Portfolio [Member]	Pre-Development Loans [Member]
				Facilities	Facilities	Facilities	loan	Wholly Owned Subsidiary [Member]	loan
								unit
Accounts, Notes, Loans and Financing Receivable [Line Items]	'	'	'	'	'	'	'	'	'
Number of Facilities, Option to Purchase Exercised	'	'	'	'	'	2	'	'	'
Acquisition of Real Estate Held-for-investment	'	'	'	'	'	$24,500,000	'	'	'
Proceeds from Collection of Loans Receivable	'	'	'	'	'	5,800,000	'	'	'
Payments to Acquire Real Estate Held-for-investment	'	'	'	'	'	18,700,000	'	'	'
Loans and Leases Receivable, Number of Loans	11	11	'	4	3	'	1	'	3
Loans and Leases Receivable, Gross	'	190,606,000	'	149,161,000	33,044,000	'	6,517,000	6,500,000	1,884,000
Loans receivable and other investments, net	'	191,529,000	'	149,648,000	33,375,000	'	6,541,000	'	1,965,000
Loans and Leases Receivable, Fixed Interest Rate	8.22%	8.22%	'	8.20%	7.50%	'	12.00%	'	9.00%
Loans And Leases Receiavble, Effective Interest Rate	8.09%	8.09%	'	8.10%	7.40%	'	11.60%	'	7.80%
Loans and Leases Receivable, Number of Units in Real Estate Property Used as Collateral	'	'	'	'	'	'	'	10	'
Loans and Leases Receivable, Option to Purchase	'	'	'	'	'	'	'	25,500,000	'
Preferred Equity Investments, Number	2	2	'	'	'	'	'	'	'
Preferred equity investment, Face Value	'	7,979,000	7,695,000	'	'	'	'	'	'
Preferred Equity Investment, Carrying Amount	'	8,074,000	'	'	'	'	'	'	'
Preferred Equity Investment, Weighted Average Contractual Rate	15.00%	15.00%	'	'	'	'	'	'	'
Preferred Equity Investment, Weighted Average Effective Rate	15.00%	15.00%	'	'	'	'	'	'	'
Number of Investments	13	13	'	'	'	'	'	'	'
Investment Owned, Balance, Principal Amount	'	198,585,000	'	'	'	'	'	'	'
Investments	'	$199,603,000	'	'	'	'	'	'	'
Investments, Weighted Average Contractual Rate	8.50%	8.50%	'	'	'	'	'	'	'
Investments, Weighted Average Effective Rate	8.40%	8.40%	'	'	'	'	'	'	'

DEBT_Details

DEBT (Details) (USD $)

3 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

3 Months Ended

0 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

1-May-14

Mar. 31, 2014

Jan. 23, 2014

23-May-13

23-May-13

23-May-13

Feb. 11, 2014

Jan. 08, 2014

Jun. 24, 2013

Mar. 31, 2014

Dec. 31, 2013

Oct. 27, 2010

Jun. 24, 2013

Mar. 31, 2014

Jul. 29, 2013

Mar. 31, 2014

Jul. 29, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Jul. 26, 2012

Mar. 31, 2014

Jan. 21, 2014

Dec. 31, 2013

5-May-14

Mar. 31, 2014

Mar. 31, 2014

Jan. 23, 2014

Subsequent Event [Member]

Revolving Credit Facility [Member]

Senior Unsecured Notes due 2021 [Member]

Senior Unsecured Notes Due 2023 [Member]

Senior Unsecured Notes Due 2023 [Member]

Senior Unsecured Notes Due 2023 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

Senior Notes due 2018 [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

2013 Revolving Credit Facility [Member]

Additional Senior Notes [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Mortgage Indebtedness [Member]

Debt Instrument, Redemption, Period One [Member]

Prior to June 2018 [Member]

Prior to June 2016 [Member]

Prior to November 2013 [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Subsequent Event [Member]

Fixed Rate Mortgages [Member]

Variable Rate Mortgages [Member]

Senior Unsecured Notes due 2021 [Member]

Minimum [Member]

Maximum [Member]

Federal Funds Rate [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

London Interbank Offered Rate (LIBOR) [Member]

Base Rate [Member]

Base Rate [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Principal Outstaning, Fixed Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$100,335,000

'

$54,688,000

'

'

'

'

Principal Outstaning, Variable Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

29,771,000

[1]

'

86,640,000

[1]

'

'

'

'

Total Principal Outstanding

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

130,106,000

'

141,328,000

'

'

'

'

Debt Instrument, Description of Variable Rate Basis

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'federal funds rate

'one-month LIBOR

'

'

'

'

'

'90-day LIBOR

'

'

'

'

'

'

Debt Instrument, Basis Spread on Variable Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.50%

1.00%

'

'

'

'

'

4.00%

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1.00%

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

'

'

'

5.50%

5.38%

'

'

'

'

'

'

'

8.13%

'

'

'

'

'

'

'

'

'

'

'

'

'

4.25%

'

4.10%

'

'

'

Expected Write-Offs in First Quarter of Next Fiscal Year Associated With Unamortized Deferred Financing Costs

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

500,000

'

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

350,000,000

200,000,000

'

'

'

'

'

'

'

225,000,000

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

44,800,000

'

11,600,000

'

'

'

Debt Instrument, Redemption Price, Principal Amount Redeemed

'

'

'

'

'

'

'

'

'

'

'

113,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed

'

'

'

'

'

'

'

'

35.00%

'

'

35.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

35.00%

Debt Instrument, Redemption Price, Percentage, Using Proceeds of Specific Kinds of Equity Offerings

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

105.50%

Proceeds from Issuance of Debt

'

'

'

'

'

350,000,000

200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Debt, Net of Issuance Costs

'

'

'

'

'

340,800,000

194,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Redeemable, Redemption Price of Principal Amount, Percentage

'

'

'

'

'

'

'

'

105.38%

'

'

'

'

'

'

108.13%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

375,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Accordion Feature, Additional Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

225,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Optional Extension Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'1 year

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Secured revolving credit facility

162,000,000

'

135,500,000

'

162,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Current Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

125,500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Interest Rate During Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2.50%

3.50%

1.50%

2.50%

'

'

'

'

'

'

'

'

Line of Credit Facility, Interest Rate at Period End

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.15%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.35%

0.50%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Expense

11,134,000

10,002,000

'

'

1,200,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Line of Credit Facility, Commitment Fee Amount

'

'

'

'

300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of deferred financing costs

945,000

766,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Interest Payable

7,700,000

'

4,700,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gain (Loss) on extinguishment of debt

-22,134,000

0

'

'

'

'

'

'

'

'

'

'

21,600,000

-9,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gains (Losses) on Extinguishment of Debt, before Write off of Deferred Debt Issuance Cost

'

'

'

'

'

'

'

'

'

'

'

'

-20,800,000

9,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Write off of Deferred Debt Issuance Cost

'

'

'

'

'

'

'

'

'

'

'

'

800,000

500,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt, Weighted Average Interest Rate

'

'

'

5.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3.97%

'

'

'

3.66%

5.00%

'

Long-term Debt

842,106,000

'

'

'

'

'

'

'

'

'

211,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

130,106,000

[2]

'

'

'

'

'

'

Extinguishment of Debt, Amount

'

'

'

'

'

'

'

'

'

$400,000

$210,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Redemption Price, Percentage

'

'

'

'

'

'

'

100.00%

'

109.49%

109.84%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

[1]

(1) Contractual interest rates under variable rate mortgages are equal to the 90-day LIBOR plus 4.0% (subject to a 1.0% LIBOR floor).

[2]

(1) Subject to a one-year extension option.

DEBT_Schedule_of_Debt_Maturiti

DEBT Schedule of Debt Maturities (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2014		Mar. 31, 2014	Mar. 31, 2014	Jan. 08, 2014
In Thousands, unless otherwise specified		Mortgage Indebtedness [Member]		Senior Notes [Member]	Line of Credit [Member]	Senior Notes due 2018 [Member]
Debt Instrument [Line Items]	'	'		'	'	'
April 1, 2014 through December 31, 2014	$2,416	$2,416	[1]	$0	$0	'
2015	31,637	31,637	[1]	0	0	'
2016	164,553	2,553	[1]	0	162,000	'
2017	2,634	2,634	[1]	0	0	'
2018	2,717	2,717	[1]	0	0	'
Thereafter	638,149	88,149	[1]	550,000	0	'
Total	$842,106	$130,106	[1]	$550,000	$162,000	$211,300
[1]	(1) Subject to a one-year extension option.

FAIR_VALUE_DISCLOSURES_Details

FAIR VALUE DISCLOSURES (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014		Mar. 31, 2013	Dec. 31, 2013
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Contingent consideration	$10,400		'	$7,500
New contingent liability	3,200		'	'
Change in fair value of contingent consideration	-300		-500	'
Loans receivable, Face Value	190,606	[1]	'	176,558	[1]
Preferred equity investment, Face Value	7,979		'	7,695
Preferred equity investments	8,236		'	'
Carrying Amount [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Loans receivable	191,529	[2]	'	177,509	[2]
Preferred equity investments	8,074		'	7,784
Fair Value [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Loans receivable	193,069		'	176,985
Preferred equity investments	8,236		'	7,950
Senior Notes [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Financial liabilities, Face Value	550,000	[1]	'	411,250	[1]
Senior Notes [Member] | Carrying Amount [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Financial liabilities	550,000	[2]	'	414,402	[2]
Senior Notes [Member] | Fair Value [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Financial liabilities	566,875		'	421,122
Mortgage indebtedness [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Financial liabilities, Face Value	130,106	[1]	'	141,328	[1]
Mortgage indebtedness [Member] | Carrying Amount [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Financial liabilities	130,106	[2]	'	141,328	[2]
Mortgage indebtedness [Member] | Fair Value [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Financial liabilities	121,208		'	130,622
Forest Park Medical Center - Frisco [Member]	'		'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'		'	'
Change in fair value of contingent consideration	$300		'	'
[1]	(1) Face value represents amounts contractually due under the terms of the respective agreements.
[2]	(2) Carrying amounts represent the book value of financial instruments and include unamortized premiums (discounts).

FAIR_VALUE_DISCLOSURES_Assets_

FAIR VALUE DISCLOSURES (Assets and Liabilities Measured on a Recurring and Nonrecurring Basis) (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Preferred equity investments	$8,236	'
Contingent consideration	10,400	7,500
Recurring [Member] | Total [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Loans receivable	193,069	'
Preferred equity investments	8,236	'
Contingent consideration	10,400	'
Recurring [Member] | Total [Member] | Senior Notes [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	566,875	'
Recurring [Member] | Total [Member] | Mortgage indebtedness [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	121,208	'
Recurring [Member] | Level 1 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Loans receivable	0	'
Preferred equity investments	0	'
Contingent consideration	0	'
Recurring [Member] | Level 1 [Member] | Senior Notes [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	0	'
Recurring [Member] | Level 1 [Member] | Mortgage indebtedness [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	0	'
Recurring [Member] | Level 2 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Loans receivable	0	'
Preferred equity investments	0	'
Contingent consideration	0	'
Recurring [Member] | Level 2 [Member] | Senior Notes [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	566,875	'
Recurring [Member] | Level 2 [Member] | Mortgage indebtedness [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	0	'
Recurring [Member] | Level 3 [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Loans receivable	193,069	'
Contingent consideration	10,400	'
Recurring [Member] | Level 3 [Member] | Senior Notes [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	0	'
Recurring [Member] | Level 3 [Member] | Mortgage indebtedness [Member]	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Financial liabilities	$121,208	'

EQUITY_Details

EQUITY (Details) (USD $)	0 Months Ended		3 Months Ended
	Jan. 23, 2014	Mar. 21, 2013	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013
Equity [Line Items]	'	'	'	'	'
Preferred stock, shares issued	'	5,750,000	5,750,000	'	5,750,000
Common dividends, declared	$0.36	'	$0.36	$0.34	'
Preferred Stock, Dividend Rate, Percentage	'	'	7.13%	'	'
Preferred Stock, Redemption Price Per Share	'	$25	'	'	'
Issuance of preferred stock	'	$138,300,000	$0	$138,983,000	'
Convertible Preferred Stock, Terms of Conversion	'	'	'1.7864	'	'
Common Stock, At The Market Stock Offering, Max Possible Gross Proceeds	'	'	100,000,000	'	'
Common Stock, At the Market Stock Offering, Sales Commision	'	'	2.00%	'	'
Common Stock, At the Market Stock Offering, Number of Shares Sold	'	'	200,000	'	'
Proceeds from Issuance of Common Stock	'	'	-648,000	-2,534,000	'
Restricted Stock Units (RSUs) [Member]	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'
Stock-based compensation, issued during period (in shares)	'	'	175,096	'	'
Stock Options [Member]	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'
Stock-based compensation, issued during period (in shares)	'	'	11,515	'	'
At-the-Market Offering, Sales Agents [Member]	'	'	'	'	'
Equity [Line Items]	'	'	'	'	'
Share Price	'	'	$27.68	'	'
Proceeds from Issuance of Common Stock	'	'	4,600,000	'	'
Payments of Stock Issuance Costs	'	'	100,000	'	'
Common Stock, Amount Available for Future Issuance	'	'	$57,100,000	'	'

EARNINGS_PER_COMMON_SHARE_Deta

EARNINGS PER COMMON SHARE (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Numerator	'	'
Net Income (Loss) Available to Common Stockholders, Basic	($9,864)	$9,253
Denominator	'	'
Weighted-average number of common shares outstanding, basic (in shares)	38,968,403	37,286,121
Dilutive stock options and restricted stock units (in shares)	0	453,843
Weighted-average number of common shares outstanding, diluted (in shares)	38,968,403	37,739,964
Basic earnings per common share (USD per shares)	($0.25)	$0.25
Dilutive earnings per common share (USD per shares)	($0.25)	$0.25

EARNINGS_PER_COMMON_SHARE_Anti

EARNINGS PER COMMON SHARE Anti-dulitve Securities excluded from Calculation (Details)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Restricted Stock Units (RSUs) [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	38,000	100
Stock Options [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	0	0

SUMMARIZED_CONDENSED_CONSOLIDA2

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Condensed Consolidating Balance Sheet) (Details) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2013	Mar. 21, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified
Assets	'	'	'	'	'
Real Estate Investment Property, Net	$1,021,704	$915,418	'	'	'
Loans receivable and other investments, net	199,603	185,293	'	'	'
Cash and cash equivalents	4,286	4,308	53,565	'	17,101
Restricted cash	6,364	5,352	'	'	'
Deferred tax assets	24,212	24,212	'	'	'
Prepaid expenses, deferred financing costs and other assets	75,187	63,252	'	'	'
Due from Affiliates	0	0	'	'	'
Investments in subsidiaries	0	0	'	'	'
Total assets	1,331,356	1,197,835	'	'	'
Liabilities and stockholders’ equity	'	'	'	'	'
Mortgage notes payable	130,106	141,328	'	'	'
Secured revolving credit facility	162,000	135,500	'	'	'
Senior unsecured notes payable	550,000	414,402	'	'	'
Accounts payable and accrued liabilities	26,315	22,229	'	'	'
Tax liability	24,212	24,212	'	'	'
Intercompany	0	0	'	'	'
Total liabilities	892,633	737,671	'	'	'
Equity	'	'	'	'	'
Preferred Stock, Value, Issued	58	58	'	'	'
Common stock	391	388	'	'	'
Additional paid-in capital	537,288	534,639	'	'	'
Cumulative distributions in excess of net income	-98,996	-74,921	'	'	'
Total Sabra Health Care REIT. Inc. stockholders’ equity	438,741	460,164	'	'	'
Stockholders' Equity Attributable to Noncontrolling Interest	-18	0	'	'	'
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	438,723	460,164	440,140	'	305,488
Total liabilities and stockholders’ equity	1,331,356	1,197,835	'	'	'
Preferred stock, par value	$0.01	$0.01	'	'	'
Preferred stock, shares authorized	10,000,000	10,000,000	'	'	'
Preferred stock, shares issued	5,750,000	5,750,000	'	5,750,000	'
Preferred stock, shares outstanding	5,750,000	5,750,000	'	'	'
Common stock, par value	$0.01	$0.01	'	'	'
Common stock, shares authorized	125,000,000	125,000,000	'	'	'
Common stock, shares issued	39,143,251	38,788,745	'	'	'
Common stock, shares outstanding	39,143,251	38,788,745	'	'	'
Parent Company [Member]	'	'	'	'	'
Assets	'	'	'	'	'
Real Estate Investment Property, Net	88	101	'	'	'
Loans receivable and other investments, net	0	0	'	'	'
Cash and cash equivalents	2,301	3,551	52,861	'	15,075
Restricted cash	0	0	'	'	'
Deferred tax assets	24,212	24,212	'	'	'
Prepaid expenses, deferred financing costs and other assets	1,235	1,217	'	'	'
Due from Affiliates	55,099	63,125	'	'	'
Investments in subsidiaries	385,248	398,640	'	'	'
Total assets	468,183	490,846	'	'	'
Liabilities and stockholders’ equity	'	'	'	'	'
Mortgage notes payable	0	0	'	'	'
Secured revolving credit facility	0	0	'	'	'
Senior unsecured notes payable	0	0	'	'	'
Accounts payable and accrued liabilities	5,230	6,470	'	'	'
Tax liability	24,212	24,212	'	'	'
Intercompany	0	0	'	'	'
Total liabilities	29,442	30,682	'	'	'
Equity	'	'	'	'	'
Preferred Stock, Value, Issued	58	58	'	'	'
Common stock	391	388	'	'	'
Additional paid-in capital	537,288	534,639	'	'	'
Cumulative distributions in excess of net income	-98,996	-74,921	'	'	'
Total Sabra Health Care REIT. Inc. stockholders’ equity	438,741	460,164	'	'	'
Stockholders' Equity Attributable to Noncontrolling Interest	0	'	'	'	'
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	438,741	'	'	'	'
Total liabilities and stockholders’ equity	468,183	490,846	'	'	'
Issuers [Member]	'	'	'	'	'
Assets	'	'	'	'	'
Real Estate Investment Property, Net	0	0	'	'	'
Loans receivable and other investments, net	0	0	'	'	'
Cash and cash equivalents	0	0	0	'	0
Restricted cash	0	0	'	'	'
Deferred tax assets	0	0	'	'	'
Prepaid expenses, deferred financing costs and other assets	13,864	9,207	'	'	'
Due from Affiliates	375,082	270,194	'	'	'
Investments in subsidiaries	553,523	537,505	'	'	'
Total assets	942,469	816,906	'	'	'
Liabilities and stockholders’ equity	'	'	'	'	'
Mortgage notes payable	0	0	'	'	'
Secured revolving credit facility	0	0	'	'	'
Senior unsecured notes payable	550,000	414,402	'	'	'
Accounts payable and accrued liabilities	7,221	3,864	'	'	'
Tax liability	0	0	'	'	'
Intercompany	0	0	'	'	'
Total liabilities	557,221	418,266	'	'	'
Equity	'	'	'	'	'
Preferred Stock, Value, Issued	0	0	'	'	'
Common stock	0	0	'	'	'
Additional paid-in capital	280,437	291,226	'	'	'
Cumulative distributions in excess of net income	104,811	107,414	'	'	'
Total Sabra Health Care REIT. Inc. stockholders’ equity	385,248	398,640	'	'	'
Stockholders' Equity Attributable to Noncontrolling Interest	0	'	'	'	'
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	385,248	'	'	'	'
Total liabilities and stockholders’ equity	942,469	816,906	'	'	'
Combined Guarantor Subsidiaries [Member]	'	'	'	'	'
Assets	'	'	'	'	'
Real Estate Investment Property, Net	850,923	751,771	'	'	'
Loans receivable and other investments, net	199,603	185,293	'	'	'
Cash and cash equivalents	0	0	0	'	0
Restricted cash	142	121	'	'	'
Deferred tax assets	0	0	'	'	'
Prepaid expenses, deferred financing costs and other assets	52,618	46,694	'	'	'
Due from Affiliates	0	0	'	'	'
Investments in subsidiaries	9,070	25,205	'	'	'
Total assets	1,112,356	1,009,084	'	'	'
Liabilities and stockholders’ equity	'	'	'	'	'
Mortgage notes payable	0	0	'	'	'
Secured revolving credit facility	162,000	135,500	'	'	'
Senior unsecured notes payable	0	0	'	'	'
Accounts payable and accrued liabilities	12,892	11,008	'	'	'
Tax liability	0	0	'	'	'
Intercompany	440,158	375,956	'	'	'
Total liabilities	615,050	522,464	'	'	'
Equity	'	'	'	'	'
Preferred Stock, Value, Issued	0	0	'	'	'
Common stock	0	0	'	'	'
Additional paid-in capital	309,490	323,574	'	'	'
Cumulative distributions in excess of net income	187,816	163,046	'	'	'
Total Sabra Health Care REIT. Inc. stockholders’ equity	497,306	486,620	'	'	'
Stockholders' Equity Attributable to Noncontrolling Interest	0	'	'	'	'
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	497,306	'	'	'	'
Total liabilities and stockholders’ equity	1,112,356	1,009,084	'	'	'
Combined Non-Guarantor Subsidiaries [Member]	'	'	'	'	'
Assets	'	'	'	'	'
Real Estate Investment Property, Net	170,693	163,546	'	'	'
Loans receivable and other investments, net	0	0	'	'	'
Cash and cash equivalents	1,985	757	704	'	2,026
Restricted cash	6,222	5,231	'	'	'
Deferred tax assets	0	0	'	'	'
Prepaid expenses, deferred financing costs and other assets	7,470	6,134	'	'	'
Due from Affiliates	9,977	42,637	'	'	'
Investments in subsidiaries	0	0	'	'	'
Total assets	196,347	218,305	'	'	'
Liabilities and stockholders’ equity	'	'	'	'	'
Mortgage notes payable	130,106	141,328	'	'	'
Secured revolving credit facility	0	0	'	'	'
Senior unsecured notes payable	0	0	'	'	'
Accounts payable and accrued liabilities	972	887	'	'	'
Tax liability	0	0	'	'	'
Intercompany	0	0	'	'	'
Total liabilities	131,078	142,215	'	'	'
Equity	'	'	'	'	'
Preferred Stock, Value, Issued	0	0	'	'	'
Common stock	0	0	'	'	'
Additional paid-in capital	34,325	48,507	'	'	'
Cumulative distributions in excess of net income	30,962	27,583	'	'	'
Total Sabra Health Care REIT. Inc. stockholders’ equity	65,287	76,090	'	'	'
Stockholders' Equity Attributable to Noncontrolling Interest	-18	'	'	'	'
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	65,269	'	'	'	'
Total liabilities and stockholders’ equity	196,347	218,305	'	'	'
Elimination [Member]	'	'	'	'	'
Assets	'	'	'	'	'
Real Estate Investment Property, Net	0	0	'	'	'
Loans receivable and other investments, net	0	0	'	'	'
Cash and cash equivalents	0	0	0	'	0
Restricted cash	0	0	'	'	'
Deferred tax assets	0	0	'	'	'
Prepaid expenses, deferred financing costs and other assets	0	0	'	'	'
Due from Affiliates	-440,158	-375,956	'	'	'
Investments in subsidiaries	-947,841	-961,350	'	'	'
Total assets	-1,387,999	-1,337,306	'	'	'
Liabilities and stockholders’ equity	'	'	'	'	'
Mortgage notes payable	0	0	'	'	'
Secured revolving credit facility	0	0	'	'	'
Senior unsecured notes payable	0	0	'	'	'
Accounts payable and accrued liabilities	0	0	'	'	'
Tax liability	0	0	'	'	'
Intercompany	-440,158	-375,956	'	'	'
Total liabilities	-440,158	-375,956	'	'	'
Equity	'	'	'	'	'
Preferred Stock, Value, Issued	0	0	'	'	'
Common stock	0	0	'	'	'
Additional paid-in capital	-624,252	-663,307	'	'	'
Cumulative distributions in excess of net income	-323,589	-298,043	'	'	'
Total Sabra Health Care REIT. Inc. stockholders’ equity	-947,841	-961,350	'	'	'
Stockholders' Equity Attributable to Noncontrolling Interest	0	'	'	'	'
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	-947,841	'	'	'	'
Total liabilities and stockholders’ equity	($1,387,999)	($1,337,306)	'	'	'

SUMMARIZED_CONDENSED_CONSOLIDA3

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Condensed Consolidating Statement of Income) (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Revenues:	'	'
Rental income	$36,093	$31,475
Interest and other income	4,757	547
Total revenues	40,850	32,022
Expenses:	'	'
Depreciation and amortization	9,350	8,246
Interest	11,134	10,002
General and administrative	5,853	4,717
Total expenses	26,337	22,965
Loss on extinguishment of debt	-22,134	0
Other income (expense)	300	500
Total other income (expense)	-21,834	500
(Income) loss in subsidiary	0	0
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	-7,321	9,557
Net Income (Loss) Attributable to Noncontrolling Interest	-18	0
Net (loss) income attributable to Sabra Health Care REIT, Inc	-7,303	9,557
Preferred stock dividends	-2,561	-304
Net income attributable to common stockholders	-9,864	9,253
Net income per common share, basic (USD per shares)	($0.25)	$0.25
Net income per common share, diluted (USD per shares)	($0.25)	$0.25
Weighted-average number of common shares outstanding, basic (in shares)	38,968,403	37,286,121
Weighted-average number of common shares outstanding, diluted (in shares)	38,968,403	37,739,964
Parent Company [Member]	'	'
Revenues:	'	'
Rental income	0	0
Interest and other income	4	54
Total revenues	4	54
Expenses:	'	'
Depreciation and amortization	13	13
Interest	0	0
General and administrative	4,692	4,584
Total expenses	4,705	4,597
Loss on extinguishment of debt	0	'
Other income (expense)	0	0
Total other income (expense)	0	0
(Income) loss in subsidiary	-2,602	14,100
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	-7,303	'
Net Income (Loss) Attributable to Noncontrolling Interest	0	'
Net (loss) income attributable to Sabra Health Care REIT, Inc	-7,303	9,557
Preferred stock dividends	-2,561	-304
Net income attributable to common stockholders	-9,864	9,253
Issuers [Member]	'	'
Revenues:	'	'
Rental income	0	0
Interest and other income	0	0
Total revenues	0	0
Expenses:	'	'
Depreciation and amortization	0	0
Interest	7,790	6,716
General and administrative	1	1
Total expenses	7,791	6,717
Loss on extinguishment of debt	-21,619	'
Other income (expense)	0	0
Total other income (expense)	-21,619	0
(Income) loss in subsidiary	26,808	20,817
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	-2,602	'
Net Income (Loss) Attributable to Noncontrolling Interest	0	'
Net (loss) income attributable to Sabra Health Care REIT, Inc	-2,602	14,100
Preferred stock dividends	0	0
Net income attributable to common stockholders	-2,602	14,100
Combined Guarantor Subsidiaries [Member]	'	'
Revenues:	'	'
Rental income	28,777	24,134
Interest and other income	4,092	493
Total revenues	32,869	24,627
Expenses:	'	'
Depreciation and amortization	7,420	6,314
Interest	1,874	1,340
General and administrative	444	114
Total expenses	9,738	7,768
Loss on extinguishment of debt	0	'
Other income (expense)	300	500
Total other income (expense)	300	500
(Income) loss in subsidiary	1,341	980
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	24,772	'
Net Income (Loss) Attributable to Noncontrolling Interest	0	'
Net (loss) income attributable to Sabra Health Care REIT, Inc	24,772	18,339
Preferred stock dividends	0	0
Net income attributable to common stockholders	24,772	18,339
Combined Non-Guarantor Subsidiaries [Member]	'	'
Revenues:	'	'
Rental income	7,316	7,341
Interest and other income	661	0
Total revenues	7,977	7,341
Expenses:	'	'
Depreciation and amortization	1,917	1,919
Interest	1,470	1,946
General and administrative	716	18
Total expenses	4,103	3,883
Loss on extinguishment of debt	-515	'
Other income (expense)	0	0
Total other income (expense)	-515	0
(Income) loss in subsidiary	0	0
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	3,359	'
Net Income (Loss) Attributable to Noncontrolling Interest	-18	'
Net (loss) income attributable to Sabra Health Care REIT, Inc	3,377	3,458
Preferred stock dividends	0	0
Net income attributable to common stockholders	3,377	3,458
Elimination [Member]	'	'
Revenues:	'	'
Rental income	0	0
Interest and other income	0	0
Total revenues	0	0
Expenses:	'	'
Depreciation and amortization	0	0
Interest	0	0
General and administrative	0	0
Total expenses	0	0
Loss on extinguishment of debt	0	'
Other income (expense)	0	0
Total other income (expense)	0	0
(Income) loss in subsidiary	-25,547	-35,897
Income (Loss) from Continuing Operations, Including Portion Attributable to Noncontrolling Interest	-25,547	'
Net Income (Loss) Attributable to Noncontrolling Interest	0	'
Net (loss) income attributable to Sabra Health Care REIT, Inc	-25,547	-35,897
Preferred stock dividends	0	0
Net income attributable to common stockholders	($25,547)	($35,897)

SUMMARIZED_CONDENSED_CONSOLIDA4

SUMMARIZED CONDENSED CONSOLIDATING INFORMATION (Condensed Consolidating Statement of Cash Flows) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	$1,207	$21,603
Cash flows from investing activities:	'	'
Acquisitions of real estate	-108,650	0
Acquisition of note receivable	-19,428	-12,873
Preferred equity investment	-5	-4,646
Additions to real estate	-56	0
Net proceeds from the sale of real estate	0	2,208
Investment in Subsidiary	0	'
Distribution from Subsidiary	'	0
Intercompany financing	0	0
Net cash used in investing activities	-128,139	-15,311
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	350,000	0
Principal payments on senior unsecured notes	-211,250	0
Proceeds from secured revolving credit facility	50,000	0
Payments on secured revolving credit facility	-23,500	-92,500
Proceeds from mortgage notes	46,103	0
Principal payments on mortgage notes payable	-57,325	-989
Payments of deferred financing costs	-9,873	-72
Issuance of preferred stock	0	138,983
Issuance of common stock	-648	-2,534
Dividends paid	-16,597	-12,716
Contributions from Parent	0	'
Distributions to Parent	'	0
Intercompany financing	0	0
Net cash provided by (used in) financing activities	126,910	30,172
Net decrease in cash and cash equivalents	-22	36,464
Cash and cash equivalents, beginning of period	4,308	17,101
Cash and cash equivalents, end of period	4,286	53,565
Parent Company [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	-10,795	20,103
Cash flows from investing activities:	'	'
Acquisitions of real estate	0	'
Acquisition of note receivable	0	0
Preferred equity investment	0	0
Additions to real estate	0	'
Net proceeds from the sale of real estate	'	0
Investment in Subsidiary	-1,165	'
Distribution from Subsidiary	'	1,851
Intercompany financing	27,955	-107,901
Net cash used in investing activities	26,790	-106,050
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	0	'
Principal payments on senior unsecured notes	0	'
Proceeds from secured revolving credit facility	0	'
Payments on secured revolving credit facility	0	0
Proceeds from mortgage notes	0	'
Principal payments on mortgage notes payable	0	0
Payments of deferred financing costs	0	0
Issuance of preferred stock	'	138,983
Issuance of common stock	-648	-2,534
Dividends paid	-16,597	-12,716
Contributions from Parent	0	'
Distributions to Parent	'	0
Intercompany financing	0	0
Net cash provided by (used in) financing activities	-17,245	123,733
Net decrease in cash and cash equivalents	-1,250	37,786
Cash and cash equivalents, beginning of period	3,551	15,075
Cash and cash equivalents, end of period	2,301	52,861
Issuers [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	0	0
Cash flows from investing activities:	'	'
Acquisitions of real estate	0	'
Acquisition of note receivable	0	0
Preferred equity investment	0	0
Additions to real estate	0	'
Net proceeds from the sale of real estate	'	0
Investment in Subsidiary	-1,165	'
Distribution from Subsidiary	'	1,851
Intercompany financing	-101,641	-107,886
Net cash used in investing activities	-102,806	-106,035
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	350,000	'
Principal payments on senior unsecured notes	-211,250	'
Proceeds from secured revolving credit facility	0	'
Payments on secured revolving credit facility	0	0
Proceeds from mortgage notes	0	'
Principal payments on mortgage notes payable	0	0
Payments of deferred financing costs	-9,154	-15
Issuance of preferred stock	'	0
Issuance of common stock	0	0
Dividends paid	0	0
Contributions from Parent	1,165	'
Distributions to Parent	'	-1,851
Intercompany financing	-27,955	107,901
Net cash provided by (used in) financing activities	102,806	106,035
Net decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Combined Guarantor Subsidiaries [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	0	0
Cash flows from investing activities:	'	'
Acquisitions of real estate	-108,650	'
Acquisition of note receivable	-19,428	-12,873
Preferred equity investment	-5	-4,646
Additions to real estate	-56	'
Net proceeds from the sale of real estate	'	0
Investment in Subsidiary	0	'
Distribution from Subsidiary	'	0
Intercompany financing	0	0
Net cash used in investing activities	-128,139	-17,519
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	0	'
Principal payments on senior unsecured notes	0	'
Proceeds from secured revolving credit facility	50,000	'
Payments on secured revolving credit facility	-23,500	-92,500
Proceeds from mortgage notes	0	'
Principal payments on mortgage notes payable	0	0
Payments of deferred financing costs	-2	-75
Issuance of preferred stock	'	0
Issuance of common stock	0	0
Dividends paid	0	0
Contributions from Parent	0	'
Distributions to Parent	'	0
Intercompany financing	101,641	110,094
Net cash provided by (used in) financing activities	128,139	17,519
Net decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Combined Non-Guarantor Subsidiaries [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	12,002	1,500
Cash flows from investing activities:	'	'
Acquisitions of real estate	0	'
Acquisition of note receivable	0	0
Preferred equity investment	0	0
Additions to real estate	0	'
Net proceeds from the sale of real estate	'	2,208
Investment in Subsidiary	0	'
Distribution from Subsidiary	'	0
Intercompany financing	0	0
Net cash used in investing activities	0	2,208
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	0	'
Principal payments on senior unsecured notes	0	'
Proceeds from secured revolving credit facility	0	'
Payments on secured revolving credit facility	0	0
Proceeds from mortgage notes	46,103	'
Principal payments on mortgage notes payable	-57,325	-989
Payments of deferred financing costs	-717	18
Issuance of preferred stock	'	0
Issuance of common stock	0	0
Dividends paid	0	0
Contributions from Parent	1,165	'
Distributions to Parent	'	-1,851
Intercompany financing	0	-2,208
Net cash provided by (used in) financing activities	-10,774	-5,030
Net decrease in cash and cash equivalents	1,228	-1,322
Cash and cash equivalents, beginning of period	757	2,026
Cash and cash equivalents, end of period	1,985	704
Elimination [Member]	'	'
Condensed Financial Statements, Captions [Line Items]	'	'
Net cash provided by operating activities	0	0
Cash flows from investing activities:	'	'
Acquisitions of real estate	0	'
Acquisition of note receivable	0	0
Preferred equity investment	0	0
Additions to real estate	0	'
Net proceeds from the sale of real estate	'	0
Investment in Subsidiary	2,330	'
Distribution from Subsidiary	'	-3,702
Intercompany financing	73,686	215,787
Net cash used in investing activities	76,016	212,085
Cash flows from financing activities:	'	'
Proceeds from issuance of senior unsecured notes	0	'
Proceeds from secured revolving credit facility	0	'
Payments on secured revolving credit facility	0	0
Proceeds from mortgage notes	0	'
Principal payments on mortgage notes payable	0	0
Payments of deferred financing costs	0	0
Issuance of preferred stock	'	0
Issuance of common stock	0	0
Dividends paid	0	0
Contributions from Parent	-2,330	'
Distributions to Parent	'	3,702
Intercompany financing	-73,686	-215,787
Net cash provided by (used in) financing activities	-76,016	-212,085
Net decrease in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	$0	$0

PRO_FORMA_FINANCIAL_INFORMATIO2

PRO FORMA FINANCIAL INFORMATION (Details) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Business Acquisition [Line Items]	'	'
Weighted-average number of common shares outstanding, basic (in shares)	38,968,403	37,286,121
Weighted-average number of common shares outstanding, diluted (in shares)	38,968,403	37,739,964
Series of Individually Immaterial Business Acquisitions [Member]	'	'
Business Acquisition [Line Items]	'	'
Business Acquisition, Pro Forma Revenue	42,322	34,733
Business Acquisition, Pro Forma Depreciation and Amortization	9,702	9,104
Business Acquisition, Pro Forma Net Income (Loss)	-8,467	10,829
Business Acquisition, Pro Forma Earnings Per Share, Basic	-0.22	0.29
Business Acquisition, Pro Forma Earnings Per Share, Diluted	-0.22	0.29
Skilled Nursing Post-Acute Facilities [Member] | Series of Individually Immaterial Business Acquisitions [Member]	'	'
Business Acquisition [Line Items]	'	'
Number of acquired properties	6	'
Senior Housing Facilities [Member] | Series of Individually Immaterial Business Acquisitions [Member]	'	'
Business Acquisition [Line Items]	'	'
Number of acquired properties	2	'

SUBSEQUENT_EVENTS_Details

SUBSEQUENT EVENTS (Details) (USD $)	0 Months Ended	3 Months Ended			0 Months Ended
	Jan. 23, 2014	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Apr. 29, 2014	1-May-14	5-May-14	Oct. 22, 2013	Apr. 29, 2014
					Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Forest Park Medical Center - Frisco [Member]	Maximum [Member]
					Renewal_Options		Dividend Declared [Member]	Beds	Subsequent Event [Member]
					unit
					memory_care_unit
					independent_living_unit
					assisted_living_unit
Subsequent Event [Line Items]	'	'	'	'	'	'	'	'	'
Common dividends, declared	$0.36	$0.36	$0.34	'	'	'	$0.38	'	'
Preferred stock dividends, declared	'	'	'	'	'	'	$0.45	'	'
Number of Beds/Units	'	'	'	'	76	'	'	54	'
Purchase price	'	'	'	'	'	'	'	$119,800,000	'
Purchase price held in escrow	'	'	'	'	'	'	'	10,500,000	'
Purchase price held in escrow, holding period	'	'	'	'	'	'	'	'20 months	'
Purchase price held in escrow, annual fee during holding period	'	'	'	'	'	'	'	500,000	'
Rental income	'	36,093,000	31,475,000	'	'	'	'	'	'
Loans and Leases Receivable, Gross	'	190,606,000	'	'	14,100,000	'	'	'	'
Loans and Leases Receivable, Fixed Interest Rate	'	8.22%	'	'	4.84%	'	'	'	'
Payments to Acquire Real Estate Held-for-investment	'	'	'	'	23,800,000	'	'	'	'
Proceeds from Collection of Notes Receivable	'	'	'	'	1,100,000	'	'	'	'
Liabilities Assumed	'	'	'	'	14,100,000	'	'	'	'
Real Estate Investment Property, Net	'	1,021,704,000	'	915,418,000	8,600,000	'	'	'	'
Lessor Leasing Arrangements, Operating Leases, Term of Contract	'	'	'	'	'15 years	'	'	'	'
Lessor Leasing Arrangements, Operating Leases, Number of Lease Renewal Options	'	'	'	'	2	'	'	'	'
Lessor Leasing Arrangements, Operating Leases, Term of Lease Renewal Options	'	'	'	'	'5 years	'	'	'	'
Lessor Leasing Arrangements, Operating Leases, Rent Escalator Percentage	'	'	'	'	3.00%	'	'	'	4.00%
Operating Leases, Expected Annual Lease Revenue	'	'	'	'	2,200,000	'	'	'	'
Repayments of Long-term Debt	'	'	'	'	'	$29,800,000	'	'	'
Debt, Weighted Average Interest Rate	'	'	'	'	'	5.00%	'	'	'